STOCK PURCHASE AGREEMENT by and among DXP ENTERPRISES, INC., PRECISION INDUSTRIES, INC. and THE SELLING STOCKHOLDERS Dated as of August 19, 2007
by
and among
DXP
ENTERPRISES, INC.,
PRECISION
INDUSTRIES, INC.
and
THE
SELLING STOCKHOLDERS
______________________
Dated
as of August 19, 2007
This
STOCK PURCHASE AGREEMENT, dated August 19, 2007 (the
“Agreement”), by and among DXP Enterprises,
Inc., a
corporation existing under the laws of Texas
(“Purchaser”), Precision Industries, Inc., a Nebraska
corporation, (the “Company”), and the stockholders of
the Company listed on the signature pages hereof under the heading “Selling
Stockholders” (collectively, the “Selling
Stockholders”).
W
I T N E
S S E T H:
WHEREAS,
the Selling Stockholders own an aggregate of (i) 472 shares of Common Stock,
Class A, $100.00 par value per share (the “Class A
Shares”), of the Company and (ii) 160 shares of Common Stock, Class
B, $100.00 par value per share (the “Class B Shares”;
and collectively with the Class A Shares, the “Shares”),
which collectively constitute all of the issued and outstanding shares of
capital stock of the Company;
WHEREAS,
the Selling Stockholders desire to sell to Purchaser, and Purchaser desires
to
purchase from the Selling Stockholders, the Shares for the purchase price
and
upon the terms and conditions hereinafter set forth; and
WHEREAS,
certain terms used in this Agreement are defined in
Section 1.1;
NOW,
THEREFORE, in consideration of the premises and the mutual covenants
and agreements hereinafter contained, the parties hereby agree as
follows:
DEFINITIONS
Certain
Definitions. For purposes of this Agreement, the following terms
shall have the meanings specified in this Section 1.1:
“Affiliate”
means, with respect to any Person, any other Person that, directly or indirectly
through one or more intermediaries, controls, or is controlled by, or is
under
common control with, such Person, and the term “control”
(including the terms “controlled by” and
“under common
control with”) means the possession,
directly or indirectly, of the power to direct or cause the direction of
the
management and policies of such Person, whether through ownership of voting
securities, by contract or otherwise.
“Affiliated
Group” means any affiliated group within the meaning of Section
1504 of the Code or any comparable or analogous group under applicable
Law.
“Business”
means the business and operations of the Company and its Subsidiaries as
held by
Purchaser separate or separable from the other business and operations of
the
Purchaser and its subsidiaries (other than the Company and its Subsidiaries)
from and after the Closing in accordance with Schedule 2.8
hereof.
“Business
Day” means any day of the year on which national banking
institutions in Texas or Nebraska are open to the public for conducting business
and are not required or authorized to close.
“Closing
Bonuses” means the bonuses and payments in an aggregate amount of
approximately $3,500,000 processed for payment through the payroll of the
Company on the Closing Date (and promptly paid in accordance with such payroll
process) to current officers and employees of the Company with such bonuses
and
payments reducing the Purchase Price as contemplated under Section 2.2
hereof as a result of the transactions contemplated hereby.
“Closing
Working Capital” means (A) the consolidated Included Current Assets
of the Company and the Subsidiaries, less (B) the consolidated Included
Current Liabilities of the Company and the Subsidiaries, determined as of
the
open of business on the Closing Date.
“Code”
means the Internal Revenue Code of 1986, as amended.
“Company
Transaction Expenses” means, except as otherwise expressly set
forth in this Agreement, the aggregate amount of all out-of-pocket fees and
expenses, incurred by or on behalf of, or paid or to be paid by, the Company
or
any of the Subsidiaries in connection with the process of selling the Company
(including in respect of any previous efforts (not pursuant to this Agreement)
to sell the Company or all or substantially all of its assets) or otherwise
relating to the negotiation, preparation or execution of this Agreement or
any
documents or agreements contemplated hereby or the performance or consummation
of the transactions contemplated hereby, including (A) any fees and expenses
associated with obtaining necessary or appropriate waivers, consents or
approvals of any Governmental Body or third parties on behalf of the Company
or
any of the Subsidiaries, (B) any fees or expenses associated with obtaining
the
release and termination of any Liens; (C) all brokers’ or finders’ fees; (D)
fees and expenses of counsel, advisors, consultants, investment bankers,
accountants, and auditors and experts, and (E) all sale, “stay-around,”
retention, or similar bonuses or payments to current or former directors,
officers, employees and consultants paid as a result of or in connection
with
the transactions contemplated hereby, but shall not include the amount of
Closing Bonuses (that are paid in accordance with the requirements of such
defined term).
“Contract”
means any contract, agreement, indenture, note, bond, mortgage, loan,
instrument, lease, license, commitment or other arrangement, understanding,
undertaking, commitment or obligation.
“Controlling
Owner” means Xxxxxx X. Xxxxx.
“DXP
Business” means the business and operations of Purchaser and its
subsidiaries, as distinct and separate from the Company and its Subsidiaries
(and as held by Purchaser separate or separable therefrom from and after
the
Closing in accordance with Schedule 2.8 hereof).
“EBITDA”
means, for any applicable period, the net income (or loss) of the Business
excluding (a) extraordinary items and/or non-operating items and/or non-cash
items to the extent increasing net-income, (b) provisions for taxes based
on
income of the Business, (c) total interest expense of the Business with respect
to indebtedness held by or for the benefit of the Business, (d) to the extent
that net income of the Business has been reduced thereby, depreciation expense,
and (e) to the extent that net income for the Business has been reduced thereby,
amortization expense, all as determined using the same accounting methods,
practices, principles, policies and procedures, with consistent classifications,
judgments and valuation and estimation methodologies that were used in the
preparation of the Company’s audited Financial Statements for the most recent
fiscal year end.
“Environmental
Costs and Liabilities” means, with respect to any Person, all
liabilities, obligations, responsibilities, Remedial Actions, losses, damages
(including punitive damages and consequential damages) costs and expenses
(including all reasonable fees, disbursements and expenses of counsel, experts
and consultants and costs of investigation and feasibility studies), fines,
penalties, sanctions and interest incurred as a result of any claim or demand
by
any other Person or in response to any violation of Environmental Law, whether
accrued or contingent, whether based in contract, tort, implied or express
warranty, strict liability, criminal or civil statute or otherwise, to the
extent based upon, related to, or arising under or pursuant to any Environmental
Law, Environmental Permit, Order or agreement with any Governmental Body
or
other Person, which relates to any environmental, health or safety condition,
violation of Environmental Law or a Release or threatened Release of Hazardous
Materials.
“Environmental
Law” means any Law in any way relating to the protection of human
health and safety, the environment or natural resources including the
Comprehensive Environmental Response, Compensation and Liability Act (42
U.S.C.
§ 9601 etseq.), the Hazardous Materials Transportation Act
(49 U.S.C. App. § 1801 etseq.), the Resource
Conservation and Recovery Act (42 U.S.C. § 6901 etseq.), the
Clean Water Act (33 U.S.C. § 1251 etseq.), the Clean Air Act
(42 U.S.C. § 7401 etseq.) the Toxic Substances Control
Act (15 U.S.C. § 2601 etseq.), the Federal Insecticide,
Fungicide, and Rodenticide Act (7 U.S.C. § 136 etseq.), and
the Occupational Safety and Health Act (29 U.S.C. § 651
etseq.), as each has been or may be amended and the regulations
promulgated pursuant thereto.
“Environmental
Permit” means any Permit required by Environmental Laws for the
operation of the Company and the Subsidiaries.
“ERISA”
means the Employment Retirement Income Security Act of 1974, as
amended.
“GAAP”
means generally accepted accounting principles in the United States as of
the
date hereof.
“Governmental
Body” means any government or governmental or regulatory body
thereof, or political subdivision thereof, whether federal, state, local
or
foreign, or any agency, instrumentality or authority thereof, or any court
or
arbitrator (public or private).
“Hazardous
Material” means any substance, material or waste that is regulated,
classified, or otherwise characterized under or pursuant to any Environmental
Law as “hazardous,” “toxic,”
“pollutant,”
“contaminant,”
“radioactive,” or words of similar meaning or effect,
including petroleum and its by-products, asbestos, polychlorinated biphenyls,
radon, mold and urea formaldehyde insulation.
“HSR
Act” means the Xxxx-Xxxxx-Xxxxxx Antitrust Improvements Act of
1976, as amended, and the rules and regulations promulgated
thereunder.
“Included
Current Assets” means cash and cash
equivalents, accounts receivable, other receivables, inventory, deposits
and
prepaid expenses, determined in accordance with GAAP applied using the same
accounting methods, practices, principles, policies and procedures, with
consistent classifications, judgments and valuation and estimation methodologies
that were used in the preparation of the Company’s audited Financial Statements
for the most recent fiscal year end as if such accounts were being prepared
and
audited as of a fiscal year end; provided, however, that such
determination shall be subject to the exceptions and other qualifications
as set
forth on Schedule 2.7 hereto.
“Included
Current Liabilities” means accounts payable
and accrued expenses, but excluding the current portion of long term
Indebtedness, determined in accordance with GAAP applied using the same
accounting methods, practices, principles, policies and procedures, with
consistent classifications, judgments and valuation and estimation methodologies
that were used in the preparation of the Company’s audited Financial Statements
for the most
recent fiscal year end as if such accounts were being prepared and audited
as of
a fiscal year end; provided, however, that (i) such determination
shall be subject to the exceptions and other qualifications as set forth
on
Schedule 2.7 hereto and (ii) such Liabilities shall exclude the amount of
Closing Bonuses (that are paid in accordance with the requirements of such
defined term).
“Indebtedness”
of any Person means, without duplication, (i) the principal, accreted
value, accrued and unpaid interest, prepayment and redemption premiums or
penalties (if any), unpaid fees or expenses and other monetary obligations
in
respect of (A) indebtedness of such Person for money borrowed and
(B) indebtedness evidenced by notes, debentures, bonds or other similar
instruments for the payment of which such Person is responsible or liable;
(ii) all obligations of such Person issued or assumed as the deferred
purchase price of property, all conditional sale obligations of such Person
and
all obligations of such Person under any title retention agreement;
(iii) all obligations of such Person under leases required to be
capitalized in accordance with GAAP; (iv) all obligations of such Person
for the reimbursement of any obligor on any letter of credit, banker’s
acceptance or similar credit transaction; (v) all obligations of such Person
under interest rate or currency swap transactions (valued at the termination
value thereof); (vi) the liquidation value, accrued and unpaid dividends,
prepayment or redemption premiums and penalties (if any), unpaid fees or
expenses and other monetary obligations in respect of any redeemable preferred
stock of such Person; (vii) all obligations of the type referred to in
clauses (i) through (vi) of any Persons for the payment of which such
Person is responsible or liable, directly or indirectly, as obligor, guarantor,
surety or otherwise, including guarantees of such obligations; and
(viii) all obligations of the type referred to in clauses (i) through (vii)
of other Persons secured by (or for which the holder of such obligations
has an
existing right, contingent or otherwise, to be secured by) any Lien on any
property or asset of such Person (whether or not such obligation is assumed
by
such Person). The term “Indebtedness” does not include trade accounts
payable and other accrued current liabilities arising in the Ordinary Course
of
Business (other than the current liability portion of any indebtedness for
borrowed money).
“Indemnity
Escrow Account” means an account, set up pursuant to the Escrow
Agreement, where the Indemnity Escrow Amount is held for disbursement by
the
Escrow Agent.
“Intellectual
Property” means any rights available (including with respect to
Technology) under patent, copyright, trade secret or trademark law or any
other
similar statutory provision or common law doctrine in the United States or
anywhere else in the Territory, and also domain names.
“IRS”
means the Internal Revenue Service.
“Knowledge”
means, with respect to any Person that is not an individual, the knowledge
of
such Person’s chief executive officer, president, chief operating officer and
chief financial officer or, in the case of an individual, knowledge after
due
inquiry of the Company’s and the Subsidiaries’ books and records.
“Law”
means any foreign, federal, state or local law (including common law), statute,
code, ordinance, rule, regulation, Order or other requirement.
“Legal
Proceeding” means any judicial, administrative or arbitral actions,
suits, mediation, investigation, inquiry, proceedings or claims (including
counterclaims) by or before a Governmental Body.
“Liability”
means any debt, loss, damage, adverse claim, fines, penalties, liability
or
obligation (whether direct or indirect, absolute or contingent, accrued or
unaccrued, matured or unmatured, determined or determinable, liquidated or
unliquidated, or due or to become due, and whether in contract, tort, strict
liability or otherwise), and including all costs and expenses relating thereto
including all fees, disbursements and expenses of legal counsel, experts,
engineers and consultants and costs of investigation.
“Lien”
means any lien, pledge, mortgage, deed of trust, security interest, claim,
lease, charge, option, right of first refusal, easement, servitude, proxy,
voting trust or agreement, transfer restriction under any shareholder or
similar
agreement, encumbrance or any other restriction or limitation
whatsoever.
“Material
Adverse Effect” means a material adverse effect on (i) the
historical, near-term or long-term projected business, assets, properties,
results of operations, condition (financial or otherwise) or prospects of
the
Company or the Subsidiaries, (ii) the financial, banking, capital markets
or
general economic conditions, (iii) regulatory or political conditions, or
securities markets in the United States or worldwide or any outbreak of
hostilities, terrorist activities or war, or any material worsening of any
such
hostilities, activities or war underway as of the date hereof or (iv) the
ability of the Selling Stockholders to consummate the transactions contemplated
by this Agreement or perform their obligations under this Agreement or the
Selling Stockholder Documents; provided, in each case, that any such effect
has
a non-annualized negative impact on the EBITDA of the Company and its
Subsidiaries in an amount of at least $750,000.
“Order”
means any order, injunction, judgment, doctrine, decree, ruling, writ,
assessment or arbitration award of a Governmental Body.
“Ordinary
Course of Business” means the ordinary and usual course
of operations of the business of the Company and the Subsidiaries
through the date hereof consistent with past practice (including, without
limitation, operations as conducted and reflected in the Company’s audited
Financial Statements for the most recent fiscal year).
“Permits”
means any approvals, authorizations, consents, licenses, permits or certificates
of a Governmental Body.
“Permitted
Exceptions” means (i) all defects, exceptions, restrictions,
easements, rights of way and encumbrances disclosed in policies of title
insurance which have been delivered or made available to Purchaser; (ii)
statutory liens for current Taxes, assessments or other governmental charges
not
yet delinquent or the amount or validity of which is being contested in good
faith by appropriate proceedings, provided an appropriate reserve has been
established herefore in the Financial Statements in accordance with GAAP;
(iii)
mechanics’, carriers’, workers’, and repairers’ Liens arising or incurred in the
Ordinary Course of Business that are not material to the business, operations
and financial condition of the Company Property so encumbered and that are
not
resulting from a breach, default or violation by the Company or any of the
Subsidiaries of any Contract or Law; and (iv) zoning, entitlement and other
land use and environmental regulations by any Governmental Body, provided
that such regulations have not been violated.
“Person”
means any individual, corporation, limited liability company, partnership,
firm,
joint venture, association, joint-stock company, trust, unincorporated
organization, Governmental Body or other entity.
“Pre-Closing
Covenant” means a covenant or other agreement set forth in this
Agreement that by its nature is required to be performed by or prior to the
Closing.
“Precision
de Mexico” means Precision Industries de Mexico, S. de X.X. de
C.V.
“Program
Synergies” means the dollar amount of actual and realized
incentives, commissions and rebates based upon, attributable to, resulting
and
accrued from Alliance Marketing Commissions, inventory purchasing incentive
and
other rebate programs provided by suppliers of inventory purchases of the
Company and its Subsidiaries (whether arising from programs that are new
to
Purchaser due to the purchase of the Company and its Subsidiaries hereunder
or
from existing programs in which the DXP Business currently participates (which
are evidenced in documentation provided by Purchaser to the Controlling Owner),
except that only the incremental Alliance Marketing Commissions, incentive,
and
rebate revenue provided thereby shall be counted for existing programs in
which
the DXP Business participates) that become available and accrue to the benefit
of the DXP Business from and after the Closing.
“Release”
means any release, spill, emission, leaking, pumping, poring, injection,
deposit, dumping, emptying, disposal, discharge, dispersal, leaching or
migration into the indoor or outdoor environment, or into or out of any
property.
“Remedial
Action” means all actions including any capital expenditures
undertaken to (i) clean up, remove, treat or in any other way address any
Hazardous Material; (ii) prevent the Release or threat of Release, or minimize
the further Release of any Hazardous Material so it does not migrate or endanger
or threaten to endanger public health or welfare or the indoor or outdoor
environment; (iii) perform pre-remedial studies and investigations or
post-remedial monitoring and care; or (iv) to correct a condition of
noncompliance with Environmental Laws.
“Securities
Act” means the Securities Act of 1933, as amended.
“Software”
means any and all computer programs, whether in source code or object code;
databases and compilations, whether machine readable or otherwise; descriptions,
flow-charts and other work product used to design, plan, organize and develop
any of the foregoing; and all documentation including user manuals and other
training documentation related to any of the foregoing.
“Subsidiary”
means any Person of which (i) a majority of the outstanding share capital,
voting securities or other equity interests are owned, directly or indirectly,
by the Company or (ii) the Company is entitled, directly or indirectly, to
appoint a majority of the board of directors, board of managers or comparable
body of such Person.
“Target
Working Capital” means an amount equal to $41,940,112.
“Taxes”
means (i) all federal, state, local or foreign taxes, charges, fees, imposts,
levies or other assessments, including all income, gross receipts, capital,
sales, use, ad valorem, value added, transfer, franchise, profits, inventory,
capital stock, license, withholding, payroll, employment, social security,
unemployment, excise, severance, stamp, occupation, property and estimated
taxes, customs duties, fees, assessments and charges of any kind whatsoever,
(ii) all interest, penalties, fines, additions to tax or additional amounts
imposed by any Taxing Authority in connection with any item described in
clause
(i) and (iii) any transferee liability in respect of any items described
in
clauses (i) or (ii) payable by reason of Contract, assumption, transferee
liability, operation of Law, Treasury Regulation Section 1.1502-6(a) (or
any
predecessor or successor thereof of any analogous or similar provision under
Law) or otherwise.
“Taxing
Authority” means the IRS an any other Governmental Body responsible
for the administration of any Tax.
“Tax
Return” means any return, report or statement required to be filed
with respect to any Tax (including any elections, declarations, schedules
or
attachments thereto, and any amendment thereof) including any information
return, claim for refund, amended return or declaration of estimated Tax,
and
including, where permitted or required, combined, consolidated or unitary
returns for any group of entities that includes the Company, any of the
Subsidiaries, or any of their Affiliates.
“Technology”
means, collectively, designs, formulae, algorithms, procedures, methods,
techniques, ideas, know-how, results of research and development, Software,
tools, data, inventions, apparatus, creations, improvements, works of authorship
and other similar materials, and all recordings, graphs, drawings, reports,
analyses, and other writings, and any other embodiments of the above, in
any
form whether or not specifically listed herein, and all related technology,
that
are used, incorporated, or embodied in or displayed by any of the foregoing
or
used in the design, development, reproduction, sale, marketing, maintenance
or
modification of any of the foregoing.
“Territory”
means the territory comprised by the geographic locations (whether of
metropolitan areas, counties, parishes or other relevant political subdivisions)
of Canada, Mexico and the United States in which the Company and its
Subsidiaries have conducted business and operations, including, without
limitation, those locations into which the Company and its Subsidiaries have
made contact with any actual or prospective customer or supplier or otherwise
sought business arrangements or a relationship.
“Trust”
means the “Xxxxxx X. Xxxxx Irrevocable Trust No. 4”, which is a Selling
Stockholder hereunder.
“WARN”
means the Worker Adjustment and Retraining Notification Act of 1988, as
amended.
1.1 Terms
Defined Elsewhere in this Agreement. For purposes of this
Agreement, the following terms have meanings set forth in the sections
indicated:
Term
|
Section
|
Acquisition
Transaction
|
6.6(a)
|
Agreement
|
Recitals
|
Allocation
Statement
|
8.5(b)(iv)
|
Antitrust
Division
|
6.4(a)
|
Antitrust
Laws
|
6.4(b)
|
Balance
Sheet
|
4.7(a)
|
Balance
Sheet Date
|
4.7(a)
|
Cap
|
8.4(c)
|
Class
A Shares
|
Recitals
|
Class
B Shares
|
Recitals
|
Closing
|
2.4
|
Closing
Balance Sheet
|
2.7(b)
|
Closing
Date
|
2.4
|
Closing
Working Capital Statement
|
2.7(b)
|
COBRA
|
4.15(p)
|
Common
Stock
|
4.4(a)
|
Company
|
Recitals
|
Company
Documents
|
4.2
|
Company
Permits
|
4.18(b)
|
Company
Plans
|
4.15(a)
|
Company
Properties
|
4.11(b)
|
Confidential
Information
|
6.7(c)
|
Confidentiality
Agreement
|
6.1
|
Covenant
Basket
|
8.4(b)
|
Distributable
Assets
|
6.2(c)
|
Employees
|
4.15(a)
|
ERISA
Affiliate
|
4.15(a)
|
Escrow
Agent
|
8.6
|
Escrow
Agreement
|
8.6
|
Expenses
|
9.3
|
Final
Closing Working Capital
|
2.7(c)
|
Financial
Statements
|
4.7(a)
|
Financing
|
5.7
|
FIRPTA
Affidavit
|
2.6(h)
|
FTC
|
6.4(a)
|
Government
Contract
|
4.28
|
Indemnity
Escrow Amount
|
8.6
|
Losses
|
8.2(a)
|
Material
Contracts
|
4.14(a)
|
Multiemployer
Plan
|
4.15(a)
|
PBGC
|
4.15(i)
|
Personal
Property Leases
|
4.12(b)
|
Purchase
Price
|
2.2
|
Purchaser
|
Recitals
|
Purchaser
Documents
|
5.2
|
Purchaser’s
Environmental Assessment
|
6.10(a)
|
Purchaser
Indemnified Parties
|
8.2(a)
|
QSSS
|
4.10(v)
|
Real
Property Lease
|
4.11(b)
|
Related
Persons
|
4.23
|
Rep
Basket
|
8.4(a)
|
Rep
Deductible
|
8.4(a)
|
Representatives
|
6.6(a)
|
Restricted
Business
|
6.7(a)
|
Section
338(h)(10) Election
|
8.5(b)(i)
|
Selling
Stockholders
|
Recitals
|
Selling
Stockholder Documents
|
3.2
|
Selling
Stockholder Indemnified Parties
|
8.2(b)
|
Stockholder
Representative
|
10.2(a)
|
Straddle
Period
|
8.5(d)
|
Shares
|
Recitals
|
Survival
Period
|
8.1(a)
|
Tax
Claim
|
8.5(e)(i)
|
Termination
Date
|
9.1(a)
|
Third
Party Claim
|
8.3(b)
|
Title
IV Plans
|
4.15(a)
|
Unresolved
Claims
|
8.6
|
1.2 Other
Definitional and Interpretive Matters.
· Unless
otherwise expressly provided, for purposes of this Agreement, the following
rules of interpretation shall apply:
Calculation
of Time Period. When calculating the period of time before which,
within which or following which any act is to be done or step taken pursuant
to
this Agreement, the date that is the reference date in calculating such period
shall be excluded. If the last day of such period is a non-Business
Day, the period in question shall end on the next succeeding Business
Day.
Dollars. Any
reference in this Agreement to $ shall mean U.S. dollars.
Exhibits/Schedules. The
Exhibits and Schedules to this Agreement are hereby incorporated and made
a part
hereof and are an integral part of this Agreement. All Exhibits and
Schedules annexed hereto or referred to herein are hereby incorporated in
and
made a part of this Agreement as if set forth in full herein. Any
capitalized terms used in any Schedule or Exhibit but not otherwise defined
therein shall be defined as set forth in this Agreement.
Gender
and Number. Any reference in this Agreement to gender shall
include all genders, and words imparting the singular number only shall include
the plural and vice versa.
Headings. The
provision of a Table of Contents, the division of this Agreement into Articles,
Sections and other subdivisions and the insertion of headings are for
convenience of reference only and shall not affect or be utilized in construing
or interpreting this Agreement. All references in this Agreement to
any “Section” are to the corresponding Section of this Agreement unless
otherwise specified.
Herein. The
words such as “herein,” “hereinafter,” “hereof,” and
“hereunder” refer to this Agreement as a whole and not
merely to a
subdivision in which such words appear unless the context otherwise
requires.
Including. The
word “including” or any variation thereof means “including, without
limitation” and shall not be construed to limit any general statement that
it follows to the specific or similar items or matters immediately following
it.
· The
parties hereto have participated jointly in the negotiation and drafting of
this
Agreement and, in the event an ambiguity or question of intent or interpretation
arises, this Agreement shall be construed as jointly drafted by the parties
hereto and no presumption or burden of proof shall arise favoring or disfavoring
any party by virtue of the authorship of any provision of this
Agreement.
SALE
AND PURCHASE OF SHARES, PURCHASE PRICE; CLOSING
1.3 Sale
and Purchase of Shares. Upon the terms and subject to the
conditions contained herein, on the Closing Date, each Selling Stockholder
agrees to sell to Purchaser, free and clear of any and all Liens, and Purchaser
agrees to purchase from each Selling Stockholder, the Shares owned by such
Selling Stockholder set forth opposite such Selling Stockholder’s name on
Exhibit A hereto.
1.4 Purchase
Price. The aggregate purchase price to be paid by Purchaser for
the Shares shall be an amount in cash equal to $106,000,000.00 less an
amount equal to (i) any consolidated Indebtedness of the Company and the
Subsidiaries as of the close of business on the day immediately preceding the
Closing Date plus (ii) the amount of Closing Bonuses (such amount as
reduced under clauses (i) and (ii) hereof, the “Purchase
Price”), subject to adjustment as provided under Sections
2.7, 2.8 and 8.7.
1.5 Payment
of Purchase Price.
· On
the Closing Date, Purchaser shall pay the Purchase Price less the
Indemnity Escrow Amount to the Selling Stockholders by wire transfer of
immediately available funds into accounts designated in writing by the Selling
Stockholders not less than three Business Days prior to the Closing Date and
allocated among the Selling Stockholders in accordance with their respective
aggregate percentage ownership of the Shares as set forth on Exhibit
A.
· On
the Closing Date, Purchaser shall pay the Indemnity Escrow Amount to the Escrow
Agent in cash payable by wire transfer of immediately available funds for
deposit into the Indemnity Escrow Account. The deposit of the
Indemnity Escrow Amount to the Escrow Agent in accordance with the terms of
this
Agreement shall be deemed not to be a failure to pay the Purchase Price
hereunder.
· On
the Closing Date, Purchaser (for and on behalf of the Company) shall pay, by
wire transfer of immediately available funds, an amount equal to the Closing
Bonuses to the Company for payment through its payroll system to the officers
and employees of the Company that are the recipients thereof (and the Company
shall be entitled to withhold in respect of such payments to such officers
and
employees any employment-related Taxes as required by applicable federal and
state withholding Laws).
1.6 Closing
Date. The consummation of the sale and purchase of the Shares
provided for in Section 2.1 hereof (the
“Closing”) shall take place at the offices of XxXxxxx
North Xxxxxx & Xxxxx, PC LLO located at First National Tower, Suite 3700,
0000 Xxxxx Xxxxxx, Xxxxx, Xxxxxxxx 00000-0000 (or at such other place as the
parties may designate in writing) at 10:00 a.m. (Omaha time) on a date to be
specified by the parties (the “Closing Date”), which
date shall be no later than the third Business Day after the satisfaction or
waiver of the conditions set forth in Article VII (other than conditions
that by their nature are to be satisfied at Closing, but subject to the
satisfaction or waiver of those conditions at such time), unless another time,
date or place is agreed to in writing by the parties hereto.
1.7 Deliveries
Prior to the Closing Date. No later than three Business Days
prior to the Closing Date, the Company shall deliver to Purchaser the pay-off
letters in respect of Indebtedness to be repaid as of the Closing and the
certificate setting forth an estimate of Indebtedness, each as provided in
the
first sentence of Section 6.16.
1.8 Deliveries
on the Closing Date. At the Closing, the Selling Stockholders
shall deliver or cause the Company to deliver, as applicable, to
Purchaser:
· copies
of resolutions, certified by the Secretary of the Company and an authorized
person of each Selling Stockholder, respectively, as to the authorization of
this Agreement and all of the transactions contemplated hereby;
· copies
of the releases from Affiliates of the Company, pursuant to
Section 6.12;
· stock
certificates from each of the Selling Stockholders representing the Shares,
duly
endorsed in blank or accompanied by stock transfer powers and with all requisite
stock transfer tax stamps attached and otherwise sufficient to transfer the
Shares to Purchaser free and clear of all Liens;
· all
documents required to transfer from Controlling Owner to Purchaser, free and
clear of all Liens, all title and ownership of all shares or other equity
interest (with all requisite transfer tax stamps attached and otherwise
sufficient to transfer such shares and equity interest) held by the Controlling
Owner in Precision de Mexico;
· certificates
of good standing dated not more than ten (10) Business Days prior to the Closing
Date with respect to the Company issued by the Secretary of State of the State
of Nebraska and for each state in which the Company is qualified to do business
as a foreign corporation and with respect to each Subsidiary issued by the
appropriate governmental official as to the good standing of such Subsidiary;
provided that with respect to Precision de
· Mexico,
the Selling Stockholders shall deliver instead a joint certification from said
Subsidiary’s chief executive officer and chief financial officer stating that as
at the Closing Date no action has been taken to dissolve and liquidate said
Subsidiary and that said Subsidiary is in substantial compliance with its
obligations under the Laws of Mexico;
· all
instruments and documents necessary to release any and all Liens other than
Permitted Exceptions, including appropriate UCC financing statement amendments
(termination statements);
· the
certificate indicating the amount of Indebtedness to be repaid as of the
Closing, pursuant to Section 6.16; and
· affidavits
of non-foreign status from each of the Selling Stockholders that complies with
Section 1445 of the Code (a “FIRPTA
Affidavit”).
1.9 Purchase
Price Adjustment.
· Following
the Closing, the Purchase Price shall be adjusted as provided in this Section
2.7 to reflect the difference between Final Closing Working Capital and
Target Working Capital.
· Within
ninety (90) days following the Closing Date, (i) Purchaser shall cause the
Company to prepare a consolidated balance sheet of the Company and the
Subsidiaries as of the open of business on the Closing Date (the
“Closing Balance Sheet”) and a statement of Closing
Working Capital derived from the Closing Balance Sheet (the “Closing
Working Capital Statement”), and such prepared Closing Balance
Sheet and Closing Working Capital Statement shall be delivered to the
Stockholder Representative and KPMG, LLP, the Company’s historical auditors and
(ii) the Closing Balance Sheet shall be audited by KPMG, LLP, and KPMG, LLP
shall perform the agreed-upon procedures as set forth in Schedule 2.7(b)
hereto in order to determine that the Closing Balance Sheet and the Closing
Working Capital Statement were prepared in accordance with GAAP applied using
the same accounting methods, practices, principles, policies and procedures,
with consistent classifications, judgments and valuation and estimation
methodologies that were used in the preparation of the Company’s audited
Financial Statements for the most recent fiscal year end as if such Closing
Balance Sheet was as of a fiscal year end (provided, however, that
such preparation and determination shall be subject to the limited adjustments,
exceptions and other qualifications as set forth on Schedule 2.7 hereto
so that the Closing Working Capital Statement will be determined on a basis
consistent with the Company’s historical application and interpretations
concerning determination and calculation of working capital). The
Company shall (and Purchaser shall cause the Company to) instruct KPMG, LLP
to
provide its report and any required adjustments pursuant to its audit under
clause (ii) of the immediately preceding sentence prior to the date that is
ninety (90) days following the Closing Date. Purchaser shall cause
the Company to accept any required adjustments to the Closing Balance Sheet
and
Closing Working Capital Statement as set forth in the report from KPMG, LLP,
and
each thereof, as so adjusted, shall constitute the final Closing Balance Sheet
and Closing Working Capital Statement for purposes hereof. Each of
Purchaser, on the one hand, and the Stockholder Representative (on behalf of
the
Selling Stockholders), on the other hand, shall pay one-half (1/2) of the fees,
costs and expenses of KPMG, LLP arising in
· connection
with such review and audit; provided, however, that Purchaser’s
maximum aggregate responsibility for such fees, costs and expenses shall not
exceed $30,000. Each of the Company, Selling Stockholders and
Purchaser shall, and shall cause their respective representatives and Affiliates
to, cooperate and assist in the preparation of the Closing Balance Sheet and
the
Closing Working Capital Statement and in the conduct of the review referred
to
in this Section 2.7(b). Each of Purchaser and the Stockholder
Representative shall retain their rights to dispute the final Closing Working
Capital Statement hereunder if the procedures and substance of this Section
2.7 are not complied with.
· The
Closing Working Capital as set forth in the Closing Working Capital Statement,
as adjusted in respect of the review and audit of KPMG, LLP, shall constitute
the “Final Closing Working Capital”. If Final
Closing Working Capital is greater than Target Net Working Capital, then the
Purchase Price shall be increased by the amount of such excess and Purchaser
shall pay the Stockholder Representative an amount equal to such excess together
with interest thereon from the Closing Date to the date of
payment. If Final Closing Working Capital is less than Target Net
Working Capital, then the Purchase Price shall be decreased by the amount of
such deficiency and the Selling Stockholders, jointly and severally, shall
pay
Purchaser an amount equal to such deficiency together with interest thereon
from
the Closing Date to the date of payment.
· Any
payment to be made pursuant to Section 2.7(c) shall be made at a mutually
convenient time and place within five (5) Business Days after the date on which
the applicable amount of such payment has been finally
determined. Any such payment shall be made by wire transfer of
immediately available funds. For purposes of Section 2.7(c),
applicable interest will be payable at the “prime” rate, as announced by The
Wall Street Journal, Eastern Edition, from time to time to be in effect,
calculated based on a 365 day year and the actual number of days
elapsed. Any payment to be made by Purchaser to the Selling
Stockholders under Section 2.7(c) shall be made to the Stockholder
Representative, for distribution to the Selling Stockholders in accordance
with
their respective pro rata portion of the Purchase Price.
1.10 Sellers’
Earn Outs. In addition to the amounts to be paid by the Purchaser
under Section 2.3 and, if any, Section 2.7, Purchaser shall pay to
the Stockholder Representative (for distribution to the Selling Stockholders
in
accordance with their respective pro rata portion of the Purchase
Price) additional amounts as set forth on Schedule 2.8
hereof.
REPRESENTATIONS
AND WARRANTIES RELATING TO THE SELLING STOCKHOLDERS
Each
Selling Stockholder, severally and jointly, hereby represents and warrants
to
Purchaser that:
1.11 Organization
and Good Standing. Such Selling Stockholder (other than those
that are individuals) is a limited liability company or irrevocable trust duly
organized, validly existing and, to the extent such concept is applicable,
in
good standing under the laws of
1.12 the
jurisdiction of its organization and has all requisite limited liability company
or other organizational power and authority to own, lease and operate its
properties and to carry on its business as now conducted.
1.13 Authorization
of Agreement. Such Selling Stockholder has all requisite power,
authority and legal capacity to execute and deliver this Agreement and each
other agreement, document, or instrument or certificate contemplated by this
Agreement or to be executed by such Selling Stockholder in connection with
the consummation of the transactions contemplated by this Agreement (the
“Selling Stockholder Documents”), and to consummate the
transactions contemplated hereby and thereby. The execution, delivery
and performance of this Agreement and each of the Selling Stockholder Documents,
and the consummation of the transactions contemplated hereby and thereby, has
been duly authorized and approved by all required action on the part of such
Selling Stockholder. This Agreement has been, and each of the Selling
Stockholder Documents will be at or prior to the Closing, duly and validly
executed and delivered by such Selling Stockholder and (assuming due
authorization, execution and delivery by Purchaser) this Agreement constitutes,
and each of the Selling Stockholder Documents when so executed and delivered
will constitute, legal, valid and binding obligations of such Selling
Stockholder, enforceable against such Selling Stockholder in accordance with
its
terms.
1.14 Conflicts;
Consents of Third Parties.
· None
of the execution and delivery by such Selling Stockholder of this Agreement
or
the Selling Stockholder Documents, the consummation of the transactions
contemplated hereby or thereby, or compliance by such Selling Stockholder with
any of the provisions hereof or thereof will conflict with, or result in any
violation of or default (with or without notice or lapse of time, or both)
under, or give rise to a right of termination or cancellation under any
provision of (i) with respect to those Selling Stockholders that are not
individuals, the articles of organization and operating agreement or comparable
organizational documents of such Selling Stockholder; (ii) any Contract, or
Permit to which any Selling Stockholder is a party or by which any of the
properties or assets of such Selling Stockholder are bound; (iii) any Order
of
any Governmental Body applicable to such Selling Stockholder or by which any
of
the properties or assets of such Selling Stockholder are bound; or (iv) any
applicable Law.
· No
consent, waiver, approval, Order, Permit or authorization of, or declaration
or
filing with, or notification to, any Person or Governmental Body is
required on the part of such Selling Stockholder in connection with the
execution and delivery of this Agreement, the Selling Stockholder Documents,
the
compliance by such Selling Stockholder with any of the provisions hereof, or
the
consummation of the transactions contemplated hereby, except for compliance
with
the applicable requirements of the HSR Act.
1.15 Ownership
and Transfer of Shares. Such Selling Stockholder is the record
(other than the Trust, of which Xxxxxxxxxxx X. Xxxxx is the beneficial owner)
and beneficial owner of the Shares indicated as being owned by such Selling
Stockholder on Exhibit A, free and clear of any and all
Liens. Such Selling Stockholder has the power and authority to sell,
transfer, assign and deliver such Shares as provided in this Agreement, and
such
delivery will
1.16 convey
to Purchaser good and marketable title to such Shares, free and clear of any
and
all Liens. No payments made to the Selling Stockholders, who are (or
were) employees of the Company, under this Agreement are subject to reduction
for employment-related Taxes as required by applicable federal and state
withholding Laws.
1.17 Litigation. There
is no Legal Proceeding pending or, to the Knowledge of such Selling Stockholder,
threatened against such Selling Stockholder or to which such Selling Stockholder
is otherwise a party relating to this Agreement, the Selling Stockholder
Documents or the transactions contemplated hereby or thereby.
1.18 Financial
Advisors. None of the Company, its Subsidiaries, Purchaser or any
other Purchaser Indemnified Party is or will be obligated or liable for the
payment of any fee or commission or like payment in respect of any broker,
finder or financial advisor for such Selling Stockholder in connection with
the
transactions contemplated by this Agreement.
REPRESENTATIONS
AND WARRANTIES RELATING TO THE COMPANY
The
Selling Stockholders, jointly and severally, hereby represent and warrant
to
Purchaser that:
1.19 Organization
and Good Standing. The Company is a corporation duly organized,
validly existing and in good standing under the laws of the State of Nebraska
and has all requisite corporate power and authority to own, lease and operate
its properties and to carry on its business as now conducted and as currently
proposed to be conducted. The Company is duly qualified or authorized
to do business as a foreign corporation and is in good standing under the laws
of each jurisdiction in which it owns or leases real property and each other
jurisdiction in which the conduct of its business or the ownership of its
properties requires such qualification or authorization, except where a failure
to be so qualified and authorized could not reasonably be expected to be
material.
1.20 Authorization
of Agreement. The Company has all requisite power, authority and
legal capacity to execute and deliver this Agreement and each other agreement,
document, or instrument or certificate contemplated by this Agreement or to
be
executed by the Company in connection with the transactions contemplated by
this
Agreement (the “Company Documents”), to perform its
obligations hereunder and thereunder and to consummate the transactions
contemplated hereby and thereby. The execution, delivery and
performance of this Agreement and each of the Company Documents, and the
consummation of the transactions contemplated hereby and thereby, have been
duly
authorized and approved by all required action on the part of the
Company. This Agreement has been, and each of the Company Documents
will be at or prior to the Closing, duly and validly executed and delivered
by
the Company and (assuming due authorization, execution and delivery by
Purchaser) this Agreement constitutes, and each of the Company Documents when
so
executed and delivered will constitute, legal, valid and binding obligations
of
the Company, enforceable against the Company in accordance with their respective
terms.
1.21 Conflicts;
Consents of Third Parties.
· None
of the execution and delivery by the Company of this Agreement or the Company
Documents, the consummation of the transactions contemplated hereby or thereby,
or compliance by the Company with any of the provisions hereof or thereof will
conflict with, or result in any violation or breach of, conflict with or default
(with or without notice or lapse of time, or both) under, or give rise to a
right of termination, cancellation or acceleration of any obligation or to
loss
of a material benefit under, or give rise to any obligation of the Company
to
make any payment under, or to the increased, additional, accelerated or
guaranteed rights or entitlements of any Person under, or result in the creation
of any Liens upon any of the properties or assets of Company or any Subsidiary
under, any provision of (i) the articles of incorporation and by-laws or
comparable organizational documents of the Company or any Subsidiary;
(ii) any Contract or Permit to which the Company or any Subsidiary is a
party or by which any of the properties or assets of the Company or any
Subsidiary are bound; (iii) any Order applicable to the Company or any
Subsidiary or any of the properties or assets of the Company or any Subsidiary;
or (iv) any applicable Law, except as set forth on Schedule
4.3.
· No
consent, waiver, approval, Order, Permit or authorization of, or declaration
or
filing with, or notification to, any Person or Governmental Body is
required on the part of the Company or any Subsidiary in connection with (i)
the
execution and delivery of this Agreement, the Company Documents, respectively,
the compliance by the Company with any of the provisions hereof and thereof,
or
the consummation of the transactions contemplated hereby or thereby, or
(ii) the continuing validity and effectiveness immediately following the
Closing of any Permit or Contract of the Company or any Subsidiary, except
for
(A) compliance with the applicable requirements of the HSR Act and (B) those
set
forth on Schedule 4.3.
1.22 Capitalization.
· The
authorized capital stock of the Company consists of 2,000 common shares, $100.00
par value per share (the “Common Stock”), of which 1,500
such shares are designated Common Stock, Class A, and 500 such shares are
designated Common Stock, Class B. As of the date hereof, there are
472 Class A Shares issued and outstanding, and 160 Class B Shares issued and
outstanding, and the Company does not hold any shares of Common Stock as
treasury stock. All of the issued and outstanding shares of Common
Stock were duly authorized for issuance and are validly issued, fully paid
and
non-assessable and were not issued in violation of any purchase or call option,
right of first refusal, subscription right, preemptive right or any similar
rights. All of the outstanding shares of Common Stock are owned of
record by the holders and in the respective amounts as are set forth on
Exhibit A.
· There
is no existing option, warrant, call, right or Contract to which any Selling
Stockholder or the Company is a party requiring, and there are no securities
of
the Company outstanding which upon conversion or exchange would require, the
issuance, sale or transfer of any additional shares of capital stock or other
equity securities of the Company or other securities convertible into,
exchangeable for or evidencing the right to subscribe for or purchase shares
of
capital stock or other equity securities of the Company. There are no
obligations, contingent or otherwise, of the Company or any Subsidiary to (i)
repurchase, redeem or otherwise acquire any shares of Common Stock or the
capital stock or other equity interests of any
Subsidiary, or (ii) provide material funds to, or make any material investment
in (in the form of a loan, capital contribution or otherwise), or provide any
guarantee with respect to the obligations of, any Person. There are
no outstanding stock appreciation, phantom stock, profit participation or
similar rights with respect to the Company or any of the
Subsidiaries. There are no bonds, debentures, notes or other
indebtedness of the Company or the Subsidiaries having the right to vote or
consent (or, convertible into, or exchangeable for, securities having the right
to vote or consent) on any matters on which stockholders (or other
equityholders) of the Company of the Subsidiaries may vote. There are
no voting trusts, irrevocable proxies or other Contracts or understandings
to
which the Company or any Subsidiary or any Selling Stockholder is a party or
is
bound with respect to the voting or consent of any shares of Common Stock or
the
equity interests of any Subsidiary.
1.23 Subsidiaries. Schedule
4.5 sets forth the name of each Subsidiary, and, with respect to each
Subsidiary, the jurisdiction in which it is incorporated or organized, the
jurisdictions, if any, in which it is qualified to do business, the number
of
shares of its authorized capital stock, the number and class of shares thereof
duly issued and outstanding, the names of all stockholders or other equity
owners and the number of shares of stock owned by each stockholder or the amount
of equity owned by each equity owner. Each Subsidiary is a duly
organized and validly existing corporation, partnership or other entity in
good
standing under the laws of the jurisdiction of its incorporation or organization
and is duly qualified or authorized to do business as a foreign corporation
or
entity and is in good standing under the laws of each jurisdiction in which
the
conduct of its business or the ownership of its properties requires such
qualification or authorization, except where a failure to be so qualified and
authorized could not reasonably be expected to be material. Each
Subsidiary has all requisite corporate or entity power and authority to own
its
properties and carry on its business as presently conducted. The
outstanding shares of capital stock or equity interests of each Subsidiary
are
validly issued, fully paid and non-assessable and were not issued in violation
of any purchase or call option, right of first refusal, subscription right,
preemptive right or any similar right. All such shares or other
equity interests represented as being owned by the Company or any of the
Subsidiaries are owned by them free and clear of any and all
Liens. No shares of capital stock are held by any Subsidiary as
treasury stock. There is no existing option, warrant, call, right or
Contract to which any Subsidiary is a party requiring, and there are no
convertible securities of any Subsidiary outstanding which upon conversion
would
require, the issuance of any shares of capital stock or other equity interests
of any Subsidiary or other securities convertible into shares of capital stock
or other equity interests of any Subsidiary. Except as set forth on
Schedule 4.5, the Company does not own, directly or indirectly, any
capital stock or equity securities of any Person other than the
Subsidiaries. Except as set forth on Schedule 4.5, there are
no material restrictions on the ability of the Subsidiaries to make
distributions of cash to their respective equity holders.
1.24 Corporate
Records.
· The
Company has made available to Purchaser true, correct and complete copies of
the
articles of incorporation (each certified by the Secretary of State or other
appropriate official of the applicable jurisdiction of organization) and by-laws
(each certified by the secretary, assistant secretary or other appropriate
officer) or comparable organizational documents of the Company and each of
the
Subsidiaries in each case as amended and in effect on the due date hereof,
including all amendments thereto.
· The
minute books of the Company and each Subsidiary previously made available to
Purchaser contain true and correct records of all meetings and accurately
reflect all other corporate action of the shareholders and board of directors
(including committees thereof) of the Company and the
Subsidiaries. The stock certificate books and stock transfer ledgers
of the Company and the Subsidiaries previously made available to Purchaser
are
true, correct and complete. All stock transfer taxes levied, if any,
or payable with respect to all transfers of shares of the Company and the
Subsidiaries prior to the date hereof have been paid and appropriate transfer
tax stamps affixed.
1.25 Financial
Statements.
· The
Company has delivered to Purchaser copies of (i) the audited consolidated
balance sheets of the Company and the Subsidiaries as at December 31, 2006,
2005
and 2004 and the related audited consolidated statements of income and of cash
flows of the Company and the Subsidiaries for the years then ended and
(ii) the unaudited consolidated balance sheet of the Company and the
Subsidiaries as at June 25, 2007 and the related consolidated statements of
income and cash flows of the Company and the Subsidiaries for the six-month
period then ended (such audited and unaudited statements, including the related
notes and schedules thereto, are referred to herein as the “Financial
Statements”). Each of the Financial Statements is
complete and correct, has been prepared in accordance with GAAP consistently
applied by the Company without modification of the accounting principles used
in
the preparation thereof throughout the periods presented and presents fairly
in
all material respects the consolidated financial position, results of operations
and cash flows of the Company and the Subsidiaries as at the dates and for the
periods indicated therein (provided, however, that the existence
of ineligible inventory or ineligible accounts receivable in the amounts as
reflected in Schedule 2.7 shall not be a breach of this or any other
representation in this Agreement).
The
consolidated balance sheet of the Company and the Subsidiaries as at December
27, 2006 is referred to herein as the “Balance Sheet”
and December 27, 2006 is referred to herein as
the “Balance Sheet
Date.”
All
books, records and accounts of the
Company and the Subsidiaries are accurate and complete and are maintained
in all
material respects in accordance with good business practice and all applicable
Laws.
· The
financial projections and business plan provided by the Company to Purchaser
prior to the date hereof were reasonably prepared on a basis reflecting
management’s best estimates, assumptions and judgments, at the time provided to
Purchaser, as to the future financial performance of the Company and the
Subsidiaries. Purchaser acknowledges that such projections and
business plan are based on the current knowledge of the Company, as well as
assumptions the Company’s management believes to be reasonable, that such
information and assumptions contain known and unknown risks and uncertainties,
and that actual results may differ due to factors, including changes in the
Company’s operating environment, market changes, the success of the Company in
implementing its business plan, competitive conditions in the Company’s industry
and other factors.
· The
Company has provided to Purchaser copies of all issued auditors’ reports
relating to the Company or any of the Subsidiaries and their respective
operations, whether the same are issued to the Company or any of its
Subsidiaries. The Company has not received, or been provided, any
letters to management regarding accounting practices relating to the Company
or
any of the Subsidiaries and their respective operations, whether the same are
issued to the Company or any of its Subsidiaries, during any of the periods
covered by the Financial Statements.
1.26 No
Undisclosed Liabilities. Neither the Company nor any Subsidiary
has any Liabilities of any kind that would have been required to be reflected
in, reserved against or otherwise described on the Balance Sheet or in the
notes
thereto in accordance with GAAP and were not so reflected, reserved against
or
described, other than (i) Liabilities incurred in the Ordinary Course of
Business since the Balance Sheet Date and (ii) Liabilities incurred in
connection with the transactions contemplated hereby (including, without
limitation, Company Transaction Expenses).
1.27 Absence
of Certain Developments. Except as expressly contemplated by this
Agreement or as set forth on Schedule 4.9, since the Balance Sheet
Date (i) the Company and the Subsidiaries have conducted their respective
businesses only in the Ordinary Course of Business and (ii) there has not been
any event, change, occurrence or circumstance that, individually or in the
aggregate with any such events, changes, occurrences or circumstances, has
had
or could reasonably be expected to have a Material Adverse
Effect. Without limiting the generality of the foregoing, except as
set forth on Schedule 4.9, since the Balance Sheet Date:
· there
has not been any damage, destruction or loss, whether or not covered by
insurance, with respect to the property and assets of the Company or any
Subsidiary having a replacement cost of more than $100,000 for any single loss
or $250,000 for all such losses;
· there
has not been any declaration, setting aside or payment of any dividend or other
distribution in respect of any shares of capital stock of the Company or any
repurchase, redemption or other acquisition by the Company or any Subsidiary
of
any outstanding shares of capital stock or other securities of, or other
ownership interest in, the Company or any Subsidiary;
· except
in the Ordinary Course of Business, neither the Company nor any Subsidiary
has
awarded or paid any bonuses to employees of the Company or any Subsidiary except
to the extent accrued on the Balance Sheet, or entered into any employment,
deferred compensation, severance or similar agreement (nor amended any such
agreement) or agreed to increase the compensation payable or to become payable
by it to any of the Company’s or any Subsidiary’s directors, officers,
employees, agents or representatives or agreed to increase the coverage or
benefits available under any severance pay, termination pay, vacation pay,
company awards, salary continuation for disability, sick leave, deferred
compensation, bonus or other incentive compensation, insurance, pension or
other
employee benefit plan, payment or arrangement made to, for or with such
directors, officers, employees, agents or representatives;
· there
has not been any change by the Company or any Subsidiary in accounting or Tax
reporting principles, methods or policies;
· neither
the Company nor any Subsidiary has made or rescinded any election relating
to
Taxes or settled or compromised any claim relating to Taxes;
· [omitted];
· neither
the Company nor any Subsidiary has failed to promptly pay and discharge current
liabilities except where disputed in good faith by appropriate
proceedings;
· neither
the Company nor any Subsidiary has made any loans, advances or capital
contributions to, or investments in, any Person or paid any fees or expenses
to
any Selling Stockholder or any director, officer, partner, stockholder or
Affiliate of any Selling Stockholder (other than reimbursements of business
expenses incurred and reimbursed in the Ordinary Course of
Business);
· neither
the Company nor any Subsidiary has (A) mortgaged, pledged or subjected to any
Lien any of its assets, or (B) acquired any assets or sold, assigned,
transferred, conveyed, leased or otherwise disposed of any assets of the Company
or any Subsidiary, except, in the case of clause (B), for assets acquired,
sold,
assigned, transferred, conveyed, leased or otherwise disposed of in the Ordinary
Course of Business;
· [omitted];
· neither
the Company nor any Subsidiary has amended, canceled, terminated, relinquished,
waived or released any Contract or right except in the Ordinary Course of
Business or which, in the aggregate, would not be material to the Company and
the Subsidiaries taken as a whole;
· neither
the Company nor any Subsidiary has made or committed to make any capital
expenditures or capital additions or betterments in excess of $100,000
individually or $2,500,000 in the aggregate;
· [omitted];
· the
Company has not granted any license or sublicense of any rights under or with
respect to any Intellectual Property owned by the Company or any of its
Subsidiaries except in the Ordinary Course of Business;
· neither
the Company nor any Subsidiary has instituted or settled any Legal Proceeding
resulting in a loss of revenue in excess of $250,000 in the aggregate;
and
· none
of the Selling Stockholders or the Company has agreed, committed, arranged
or
entered into any understanding to do anything set forth in this Section
4.9.
1.28 Taxes.
· Except
as set forth on Schedule 4.10(a): (i) (A) all material Tax
Returns required to be filed by or on behalf of each of the Company, any
Subsidiary and any Affiliated
· Group
of which the Company or any Subsidiary is or was a member have been duly and
timely filed with the appropriate Taxing Authority in all jurisdictions in
which
such Tax Returns are required to be filed (after giving effect to any valid
extensions of time in which to make such filings), and all such Tax Returns
are
true, complete and correct in all material respects; and (B) all Taxes required
to be paid by or on behalf of each of the Company, any Subsidiary and any
Affiliated Group of which the Company or any Subsidiary is or was a member
have
been fully and timely paid; (ii) with respect to any period for which Tax
Returns have not yet been filed or for which Taxes are not yet due or owing,
the
Company has made due and sufficient accruals for such Taxes in the Financial
Statements and its books and records; and (iii) all required estimated Tax
payments sufficient to avoid any underpayment penalties or interest have been
made by or on behalf of the Company and each Subsidiary.
· The
Company and each Subsidiary has complied in all material respects with all
applicable Laws relating to the payment and withholding of Taxes and has duly
and timely withheld and paid over to the appropriate Taxing Authority all
amounts required to be so withheld and paid under all applicable
Laws.
· The
Company has made available to Purchaser complete copies of (i) all federal,
state, local and foreign income or franchise Tax Returns of the Company and
the
Subsidiaries relating to the taxable periods since January 1, 2001 and (ii)
any
audit report issued within the last three years relating to any Taxes due from
or with respect to the Company or any Subsidiary. Except as set forth
on Schedule 4.10(c), all income and franchise Tax Returns filed by or on
behalf of the Company or any Subsidiary have been examined by the relevant
Taxing Authority or the statute of limitations with respect to such Tax Returns
has expired.
· Schedule
4.10(d) lists (i) all material types of Taxes paid, and all material types
of Tax Returns filed by or on behalf of Company or any Subsidiary, and (ii)
all
of the jurisdictions that impose such Taxes or with respect to which the Company
or any Subsidiary has a duty to file such Tax Returns. No claim has
been made by a Taxing Authority in a jurisdiction where the Company or any
Subsidiary does not file Tax Returns such that it is or may be subject to
taxation by that jurisdiction.
· All
deficiencies asserted or assessments made as a result of any examinations by
any
Taxing Authority of the Tax Returns of, or including, the Company or any
Subsidiary have been fully paid, and there are no other audits or investigations
by any Taxing Authority in progress, nor has the Selling Stockholders, the
Company or any of the Subsidiaries received any notice from any Taxing Authority
that it intends to conduct such an audit or investigation. No issue
has been raised by a Taxing Authority in any prior examination of the Company
or
any Subsidiary which, by application of the same or similar principles, could
reasonably be expected to result in a proposed deficiency for any subsequent
taxable period.
· Except
as set forth on Schedule 4.10(f), none of the Company, any Subsidiary or
any other Person on their behalf has (i) filed a consent pursuant to Section
341(f) of the Code or agreed to have Section 341(f)(2) of the Code apply to
any
disposition of a subsection (f) asset (as such term is defined in Section
341(f)(4) of the Code) owned by the Company or such Subsidiary, (ii) agreed
to
or is required to make any adjustments pursuant to Section 481(a) of the Code
or
any similar provision of Law or has any knowledge that any
· Taxing
Authority has proposed any such adjustment, or has any application pending
with
any Taxing Authority requesting permission for any changes in accounting methods
that relate to the Company or any Subsidiary, (iii) since January 1, 2000,
executed or entered into a closing agreement pursuant to Section 7121 of the
Code or any similar provision of Law with respect to the Company or any
Subsidiary, (iv) requested any extension of time within which to file any Tax
Return, which Tax Return has since not been filed, (v) granted any extension
for
the assessment or collection of Taxes, which Taxes have not since been paid,
or
(vi) granted to any Person any power of attorney that is currently in force
with
respect to any Tax matter.
· No
property owned by the Company or any Subsidiary is (i) property required to
be
treated as being owned by another Person pursuant to the provisions of Section
168(f)(8) of the Internal Revenue Code of 1954, as amended and in effect
immediately prior to the enactment of the Tax Reform Act of 1986, (ii)
“tax-exempt use property” within the meaning of Section 168(h)(1) of the Code or
(iii) “tax-exempt bond financed property” within the meaning of Section 168(g)
of the Code, (iv) “limited use property” within the meaning of Rev. Proc. 76-30,
(v) subject to Section 168(g)(1)(A) of the Code, or (vi) subject to any
provision of state, local or foreign Law comparable to any of the provisions
listed above.
· No
Selling Stockholder is a foreign person within the meaning of Section 1445
of the Code.
· Neither
the Company nor any Subsidiary is a party to any tax sharing, allocation,
indemnity or similar agreement or arrangement (whether or not written) pursuant
to which it will have any obligation to make any payments after the
Closing.
· There
is no contract, agreement, plan or arrangement covering any person that,
individually or collectively, could give rise to the payment of any amount
that
would not be deductible by Purchaser, the Company or any of their respective
Affiliates by reason of Section 280G of the Code.
· Neither
the Company nor any Subsidiary is subject to any private letter ruling of the
IRS or comparable rulings of any Taxing Authority.
· There
are no Liens as a result of any unpaid Taxes upon any of the assets of the
Company or any Subsidiary.
· Except
with respect to any period(s) closed by the applicable statute of limitations
regarding such Tax matters, neither the Company nor any of the Subsidiaries
has
ever been a member of any consolidated, combined, affiliated or unitary group
of
corporations for any Tax purposes other than a group in which the Company is
the
common parent.
· Neither
the Company nor any of the Subsidiaries has constituted either a “distributing
corporation” or a “controlled corporation” (within the meaning of Section
355(a)(1)(A) of the Code) in a distribution of stock qualifying for tax-free
treatment under Section 355 of the Code (A) in the two years prior to the date
of this Agreement or (B) in a distribution which could otherwise constitute
part
of a “plan” or “series of related transactions”
· (within
the meaning of Section 355(e) of the Code) in conjunction with the transactions
contemplated by this Agreement.
· There
is no taxable income of the Company or any of the Subsidiaries that will be
required under applicable Tax Law to be reported by the Purchaser or any of
its
Affiliates, including the Company or any of the Subsidiaries, for a taxable
period beginning after the Closing Date which taxable income was realized (and
reflects economic income) arising prior to the Closing Date.
· Except
with respect to any period(s) closed by the applicable statute of limitations
regarding such Tax matters, neither the Company nor any Subsidiary has (i)
engaged in any “intercompany transactions” in respect of which gain was and
continues to be deferred pursuant to Treasury Regulations Section 1.1502-13
or
any analogous or similar provision of Law or (ii) has any “excess loss accounts”
in respect of the stock of any Subsidiary pursuant to Treasury Regulations
Section 1.1502-19, or any analogous or similar provision of Law.
· The
Selling Stockholders, the Company and the Subsidiaries are members of a “selling
consolidated group” within the meaning of Treasury Regulation Section
1.338(h)(10)-1(b)(2).
· The
Company and the Subsidiaries have disclosed on their federal income Tax Returns
all positions taken therein that could give rise to substantial understatement
of federal income tax within the meaning of Section 6662 of the
Code.
· Other
than Precision de Mexico and I.N.T. Precision Industries of Canada, LTD./I.N.T.
Les Industries Precision du Canada, LTEE (each of which is a Subsidiary of
the
Company), neither the Company nor any of the Subsidiaries has, or has ever
had,
a permanent establishment in any country other than the United States, or has
engaged in a trade or business in any country other than the United States
that
subjected it to tax in such country.
· The
Company has been a validly electing “S” corporation within the meaning of
Sections 1361 and 1362 of the Code at all times since November 1, 1990 and
the
Company will be an “S” corporation up to and including the day before the
Closing Date.
· Except
as set forth on Schedule 4.10(u), the Company has been a validly electing
“S” corporation under each provision of state or local law analogous to
Sections
1361 and 1362 of the Code in each jurisdiction where the Company is required
to
file a Tax Return at all times since November 1, 1990 and the Company will
be an
“S” corporation up to and including the day before the Closing
Date.
· Each
Subsidiary of the Company has been a validly electing Qualified Subchapter
S
Subsidiary (a “QSSS”), within the meaning of Section
1361(b)(3) of the Code at all times since inception and each Subsidiary will
be
a QSSS up to and including the day before the Closing Date.
· The
Company has no potential liability for any Tax under Section 1374 of the
Code. Neither the Company nor any Subsidiary has, in the past ten
years, (i) acquired assets
· from
another corporation in a transaction in which such entity’s tax basis for the
acquired asset was determined, in whole, or in part, by reference to the Tax
basis of the acquired assets (or any other property) in the hands of the
transferor or (ii) acquired the stock of any corporation which is a
QSSS.
1.29 Real
Property.
· Except
as set forth on Schedule 4.11(a), neither the Company or any of the
Subsidiaries owns on the date hereof or will own as of the Closing Date any
real
property and/or interests in real property (including improvements thereon
and
easements appurtenant thereto) in fee.
· Schedule
4.11(b) sets forth a complete list of all real property and interests in
real property leased by the Company and the Subsidiaries as lessee or lessor
(including three (3) real properties which are part of the Distributable Assets
and will be distributed to an Affiliate of the Controlling Owner prior to the
Closing and then leased to the Company, each a “Real Property
Lease”, and collectively the “Company
Properties”), including a description of each such Real Property
Lease (including the name of the third party lessor or lessee and the date
of
the lease or sublease and all amendments thereto). The Company
Properties constitute all interests in real property currently used, occupied
or
currently held for use in connection with the business of the Company and the
Subsidiaries and which are necessary for the continued operation of the business
of the Company and the Subsidiaries as the business is currently
conducted. Each of the Company and the Subsidiaries, as applicable,
has a valid, binding and enforceable leasehold interest under each of the Real
Property Leases under which it is a lessee, free and clear of all Liens other
than Permitted Exceptions. Each of the Real Property Leases is in
full force and effect. Neither the Company nor an Subsidiary is in
default under any Real Property Lease, and no event has occurred and no
circumstance exists which, if not remedied, and whether with or without notice
or the passage of time or both, would result in such a
default. Neither the Company nor any Subsidiary has received or given
any notice of any default or event that with notice or lapse of time, or both,
would constitute a default by the Company or any Subsidiary under any of the
Real Property Leases and, to the Knowledge of the Company and the Selling
Stockholders, no other party is in default thereof, and no party to any Real
Property Lease has exercised any termination rights with respect
thereto. The Company has delivered to Purchaser true, correct and
complete copies of the Real Property Leases, together with all amendments,
modifications or supplements, if any, thereto.
· To
the Knowledge of the Company and the Selling Stockholders, all of the Company
Properties and buildings, fixtures and improvements thereon (i) are in good
operating condition (ordinary wear and tear excepted) without structural
defects, and all mechanical and other systems located thereon are in good
operating condition, and no condition exists requiring material repairs,
alterations or corrections and (ii) are suitable, sufficient and appropriate
in
all respects for their current and contemplated uses. None of the
improvements located on the Company Properties constitute a legal non-conforming
use or otherwise require any special dispensation, variance or special permit
under any Laws. The Company Properties are not subject to any leases,
rights of first refusal, options to purchase or rights of occupancy, except
the
Real Property Leases set forth on Schedule 4.11(b).
· The
Company and the Subsidiaries have all certificates of occupancy and Permits
of
any Governmental Body necessary or useful for the current use and operation
of
each Company Property, and the Company and the Subsidiaries have fully complied
with all material conditions of the Permits applicable to them. No
default or violation, or event that with the lapse of time or giving of notice
or both would become a default or violation, has occurred in the due observance
of any Permit.
· There
does not exist any actual or, to the Knowledge of the Company and the Selling
Stockholders, threatened or contemplated condemnation or eminent domain
proceedings that affect any Company Property or any part thereof, and none
of
the Company, and Subsidiary or any Selling Stockholder has received any notice,
oral or written, of the intention of any Governmental Body or other Person
to
take or use all or any part thereof.
· None
of the Selling Stockholders, the Company or any Subsidiary has received any
notice from any insurance company that has issued a policy with respect to
any
Company Property requiring performance of any structural or other repairs or
alterations to such Company Property.
· Neither
the Company nor any Subsidiary owns, holds, is obligated under or is a party
to,
any option, right of first refusal or other contractual right to purchase,
acquire, sell, assign or dispose of any real estate or any portion thereof
or
interest therein.
1.30 Tangible
Personal Property.
· The
Company and the Subsidiaries have good and marketable title to all of the items
of tangible personal property used in the business of the Company and the
Subsidiaries (except as sold or disposed of subsequent to the date thereof
in
the Ordinary Course of Business and not in violation of this Agreement), free
and clear of any and all Liens, other than the Permitted
Exceptions. All such items of tangible personal property which,
individually or in the aggregate, are material to the operation of the business
of the Company and the Subsidiaries are in good condition and in a state of
good
maintenance and repair (ordinary wear and tear excepted) and are suitable for
the purposes used.
· Schedule
4.12(b) sets forth all leases of personal property (“Personal
Property Leases”) involving annual payments in excess of $25,000
relating to personal property used in the business of the Company or any of
the
Subsidiaries or to which the Company or any of the Subsidiaries is a party
or by
which the properties or assets of the Company or any of the Subsidiaries is
bound. All of the items of personal property under the Personal
Property Leases are in good condition and repair (ordinary wear and tear
excepted) and are suitable for the purposes used, and such property is in all
material respects in the condition required of such property by the terms of
the
lease applicable thereto during the term of the lease. The Company
has delivered to Purchaser true, correct and complete copies of the Personal
Property Leases, together with all amendments, modifications or supplements
thereto.
· The
Company and each of the Subsidiaries has a valid and enforceable leasehold
interest under each of the Personal Property Leases under which it is a
lessee. Each of the Personal Property Leases is in full force and
effect and neither the Company nor any
· Subsidiary
has received or given any notice of any default or event that with notice or
lapse of time, or both, would constitute a default by the Company or any
Subsidiary under any of the Personal Property Leases and, to the Knowledge of
the Company and the Selling Stockholders, no other party is in default thereof,
and no party to the Personal Property Leases has exercised any termination
rights with respect thereto.
1.31 Technology
and Intellectual Property.
· Schedule
4.13(a) sets forth a complete and accurate list, as of the date of this
Agreement, of (i) each issued patent owned by the Company or any of its
Subsidiaries, (ii) each pending patent application filed by or on behalf of
the
Company or any of its Subsidiaries, (iii) each trademark registration, service
xxxx registration, and copyright registration owned by the Company or any of
its
Subsidiaries, (iv) each application for trademark registration, service xxxx
registration, and copyright registration made by or on behalf of the Company
or
any of its Subsidiaries, (v) each domain name registered by or on behalf of
the
Company or any of its Subsidiaries and (vi) each material trade name, d/b/a,
unregistered trademark, and unregistered service xxxx used by the Company or
any
of its Subsidiaries in connection with its
business. Schedule 4.13(a) lists, for each such item of
Intellectual Property owned by the Company or any of its Subsidiaries, the
item,
the jurisdiction, the filing and, if issued, issuance dates and any serial
or
registration numbers. All such Intellectual Property is subsisting,
and all necessary registration, maintenance, renewal, and other relevant filing
fees due in connection therewith have been timely paid and all necessary
documents and certificates in connection therewith have been timely filed with
the relevant patent, copyright, trademark, or other authorities in the United
States or foreign jurisdictions, as the case may be, for the purposes of
maintaining such registered Intellectual Property in full force and
effect.
· The
Company and its Subsidiaries own all right, title and interest in and to, or
have valid and continuing rights to use, all Intellectual Property, Software
and
other Technology used in the conduct of the business and operations of the
Company and its Subsidiaries as presently conducted and as currently proposed
to
be conducted, free and clear of all Liens or obligations to others.
· Except
with respect to licenses of Software (i) generally available for an annual
or
one-time license fee of no more than $10,000 in the aggregate, (ii) distributed
as “freeware” or (iii) distributed via Internet access without charge and for
use without charge, Schedule 4.13(c) sets forth a complete and accurate
as of the date of this Agreement, of all agreements pursuant to which the
Company or any of its Subsidiaries licenses in or otherwise is authorized to
use
all Intellectual Property, Software and other Technology used in the conduct
of
the business and operations of the Company and its Subsidiaries as presently
conducted and as currently contemplated to be conducted. The Company
has delivered to Purchaser correct, complete and current copies of all such
agreements.
· Following
the Closing, the Company and its Subsidiaries will have the right to exercise
all of their current rights under agreements granting rights to the Company
or
any of its Subsidiaries with respect to Intellectual Property, Software and
other Technology of a third party to the same extent and in the same manner
they
would have been able to had the transaction contemplated by this Agreement
not
occurred, and without the payment of any
· additional
consideration as a result of such transaction and without the necessity of
any
third party consent as a result of such transaction.
· All
of the material Intellectual Property owned by the Company or any of its
Subsidiaries is valid and enforceable. Since January 1, 2005 neither
the Company nor any of its Subsidiaries has brought any action, suit or
proceeding or asserted any claim (other than claims that have been resolved
to
the Company’s satisfaction) against any Person for infringing or
misappropriating any Technology or, to the Company’s Knowledge, Intellectual
Property owned by the Company or any of its Subsidiaries, nor is there any
basis
for any such action, suit or proceeding.
· There
is no action, suit, proceeding, hearing, investigation, notice or complaint
pending or, to the Company’s Knowledge, threatened, by any third party before
any court or tribunal (including, without limitation, the United States Patent
and Trademark Office or equivalent authority anywhere in the world) relating
to
any of Company’s or any of its Subsidiaries’ Intellectual Property or
Technology, nor has any claim or demand been made by any third party that (i)
challenges the validity, enforceability, use or exclusive ownership of any
Intellectual Property or Technology owned by the Company or any of its
Subsidiaries or (ii) alleges any infringement, misappropriation, violation,
or
unfair competition or trade practices by the Company or any of its Subsidiaries
of any Intellectual Property or Technology of any third party, nor is the
Company aware of any basis for any such claim or demand.
· None
of the Company’s or any of its Subsidiaries’ Technology or Intellectual Property
is subject to any outstanding injunction, decree, order, judgment, agreement
or
stipulation that restricts in any manner the use, transfer or licensing thereof
by the Company or any of its Subsidiaries or affects the validity, use or
enforceability of any such Technology or Intellectual Property.
1.32 Material
Contracts.
· Schedule
4.14(a) sets forth, by reference to the applicable subsection of this
Section 4.14(a), all of the following Contracts to which the Company or
any of the Subsidiaries is a party or by which any of them or their respective
assets of properties are bound (collectively, the “Material
Contracts”):
· Contracts
with any Selling Stockholder or Affiliate thereof or any current or former
officer, director, stockholder or Affiliate of the Company or any of the
Subsidiaries;
· Contracts
with any labor union or association representing any employee of the Company
or
any of the Subsidiaries;
· Contracts
for the sale of any of the assets of the Company or any of the Subsidiaries
other than in the Ordinary Course of Business or for the grant to any Person
of
any preferential rights to purchase any of its assets;
· Contracts
for joint ventures, strategic alliances, partnerships, licensing arrangements,
or sharing of profits or proprietary information (excluding any general
Contracts for marketing commissions or other purchasing incentive or rebate
programs);
· Contracts
containing covenants of the Company or any of the Subsidiaries not to compete
in
any material line of business or with any Person in any material geographical
area or not to solicit or hire any person with respect to employment or
covenants of any other Person not to compete with the Company or any of the
Subsidiaries in any material line of business or in any material geographical
area or not to solicit or hire any person with respect to
employment;
· Contracts
for the acquisition (by merger, purchase of stock or assets or otherwise) by
the
Company or any of the Subsidiaries of any operating business or material assets
or the capital stock of any other Person of which any operative provision
thereof is still in effect and creates an obligation of the Company or any
of
the Subsidiaries;
· Contracts
relating to the incurrence, assumption or guarantee of any Indebtedness or
imposing a Lien on any of the assets of the Company or any Subsidiary, including
indentures, guarantees, loan or credit agreements, sale and leaseback
agreements, purchase money obligations incurred in connection with the
acquisition of property, mortgages, pledge agreements, security agreements,
or
conditional sale or title retention agreements;
· all
Contracts providing for payments by or to the Company or any of the Subsidiaries
in excess of $2,000,000 in any fiscal year or $5,000,000 in the aggregate during
the term thereof;
· all
Contracts obligating the Company or any of the Subsidiaries to provide or obtain
products or services for a period of one year or more (requiring the payment
of
$2,000,000 or more) or requiring the Company to purchase or sell a stated
portion of its requirements or outputs;
· Contracts
under which the Company or any of the Subsidiaries has made advances or loans
to
any other Person (other than accounts payable arising in the Ordinary Course
of
Business);
· Contracts
providing for severance, retention, change in control or other similar
payments;
· Contracts,
involving expected payment of $150,000 or more in any annual period, for the
employment of any individual on a full-time, part-time or consulting
basis;
· material
management Contracts and Contracts with independent contractors or consultants
(or similar arrangements) that are not cancelable without penalty or further
payment and without more than 30 days’ notice; and
· outstanding
Contracts of guaranty, surety or indemnification, direct or indirect, by the
Company or any of the Subsidiaries.
· Each
of the Material Contracts is in full force and effect and is the legal, valid
and binding obligation of the Company or any Subsidiary which is party thereto,
and of the other parties thereto enforceable against each of them in accordance
with its terms and, assuming that the consents or waivers (as applicable) set
forth on Schedule 4.3 are obtained, upon consummation of the transactions
contemplated by this Agreement shall continue in full force and effect without
penalty or other adverse consequence. Neither the Company nor any
Subsidiary is in default under any Material Contract, nor, to the Knowledge
of
the Company or the Selling Stockholders, is any other party to any Material
Contract in breach of or default thereunder, and no event has occurred that
with
the lapse of time or the giving of notice or both would constitute a breach
or
default on the Company, any Subsidiary or any other party
thereunder. No party to any of the Material Contracts has exercised
any termination rights with respect thereto, and no party has given notice
of
any significant dispute with respect to any Material Contract. The
Company has made available to Purchaser true, correct and complete copies of
all
of the Material Contracts, together with all amendments, modifications or
supplements thereto.
1.33 Employee
Benefits Plans.
· Schedule
4.15(a) sets forth a correct and complete list of: (i) all
“employee benefit plans” (as defined in Section 3(3) of ERISA), and all other
employee benefit plans, programs, agreements, policies, arrangements or payroll
practices, including bonus plans, employment, consulting or other compensation
agreements, collective bargaining agreements, incentive, equity or equity-based
compensation, or deferred compensation arrangements, change in control,
termination or severance plans or arrangements, stock purchase, severance pay,
sick leave, vacation pay, salary continuation for disability, hospitalization,
medical insurance, life insurance and scholarship plans and programs maintained
by the Company or any of its Subsidiaries or to which the Company or any of
the
Subsidiaries contributed or is obligated to contribute thereunder for current
or
former employees of the Company or any of the Subsidiaries (the
“Employees”) (collectively, the “Company
Plans”), and (ii) all “employee pension plans” (as defined in
Section 3(2) of ERISA, subject to Title IV of ERISA or Section 412 of the Code,
maintained by the Company or any of its Affiliates and any trade or business
(whether or not incorporated) that is or has ever been under common control,
or
that is or has ever been treated as a single employer, with any of them under
Section 414(b), (c), (m) or (o) of the Code (each, an “ERISA
Affiliate”) or to which the Company or any ERISA Affiliate
contributed or has ever been obligated to contribute thereunder (the
“Title IV Plans”). Schedule 4.15(a)
sets forth each Company Plan and Title IV Plan that is a “multiemployer plan”
(as defined in Section 3(37) of ERISA (a “Multiemployer
Plan”)), or is or has been subject to Sections 4063 or 4064 of
ERISA.
· Correct
and complete copies of the following documents, with respect to each of the
Company Plans (other than a Multiemployer Plan), have been made available or
delivered to Purchaser by the Company, to the extent
applicable: (i) any plans, all amendments thereto and related
trust documents, insurance contracts or other funding arrangements, and
amendments thereto; (ii) the most recent Forms 5500 and all schedules
thereto and the most
· recent
actuarial report, if any; (iii) the most recent IRS determination letter;
(iv) summary plan descriptions; (v) written communications to
employees relating to the Company Plans; and (vi) written descriptions of
all non-written agreements relating to the Company Plans.
· The
Company Plans have been maintained in all material respects in accordance with
their terms and with all provisions of ERISA, the Code (including rules and
regulations thereunder) and other applicable Federal and state Laws and
regulations, and neither the Company (or any of the Subsidiaries) nor any “party
in interest” or “disqualified person” with respect to the Company Plans has
engaged in a non-exempt “prohibited transaction” within the meaning of Section
4975 of the Code or Section 406 of ERISA. No fiduciary has any
liability for breach of fiduciary duty or any other failure to act or comply
in
connection with the administration or investment of the assets of any Company
Plan.
· The
Company Plans intended to qualify under Section 401 of the Code are so qualified
and any trusts intended to be exempt from Federal income taxation under Section
501 of the Code are so exempt, and nothing has occurred with respect to the
operation of the Company Plans that could cause the loss of such qualification
or exemption or the imposition of any liability, penalty or tax under ERISA
or
the Code.
· Each
Company Plan that is intended to meet the requirements for tax-favored treatment
under Subchapter B of Chapter 1 of Subtitle A of the Code meets such
requirements.
· Neither
the Company nor any ERISA Affiliate has withdrawn in a complete or partial
withdrawal from any Multiemployer Plan prior to the Closing Date, nor have
any
of them incurred any liability due to the termination or reorganization of
a
Multiemployer Plan. Purchaser will not have (i) any obligation
to make any contribution to any Multiemployer Plan or (ii) any withdrawal
liability from any Multiemployer Plan under Section 4201 of ERISA, which it
would not have had but for the consummation of the transactions contemplated
by
this Agreement.
· Schedule
4.15(g) sets forth on a plan by plan basis, the present value of benefits
payable presently or in the future to Employees under each unfunded Company
Plan.
· All
contributions (including all employer contributions and employee salary
reduction contributions) required to have been made under any of the Company
Plans (including workers compensation) or Title IV Plans or by Law (without
regard to any waivers granted under Section 412 of the Code), to any funds
or
trusts established thereunder or in connection therewith have been made by
the
due date thereof (including any valid extension), and all contributions for
any
period ending on or before the Closing Date that are not yet due will have
been
paid or sufficient accruals for such contributions and other payments in
accordance with GAAP are duly and fully provided for on the Balance
Sheet. No accumulated funding deficiencies exist in any of the
Company Plans or Title IV Plans subject to Section 412 of the Code.
· There
is no “amount of unfunded benefit liabilities” (as defined in Section
4001(a)(18) of ERISA) in any of the Title IV Plans. Each of the Title
IV Plans are fully funded in accordance with the actuarial assumptions used
by
the Pension Benefit Guaranty Corporation (“PBGC”) to
determine the level of funding required in the event of the termination of
a
Title IV Plan and the “benefit liabilities” (as defined in Section 4001(a)(16)
of ERISA) of such Title IV Plan using such PBGC assumptions do not exceed the
assets of such Title IV Plan.
· There
has been no “reportable event” (as defined in Section 4043 of ERISA) with
respect to the Title IV Plans that would require the giving of notice or any
event requiring disclosure under Section 4041(c)(3)(C) or 4063(a) of
ERISA.
· Neither
the Company nor any ERISA Affiliate has terminated any Title IV Plan, or
incurred any outstanding liability under Section 4062 of ERISA to the PBGC
or to
a trustee appointed under Section 4042 of ERISA. All premiums due the
PBGC with respect to the Title IV Plans have been paid.
· No
liability under any Company Plan or Title IV Plan has been funded nor has any
such obligation been satisfied with the purchase of a contract from an insurance
company that is not rated AA by Standard & Poor’s Corporation or the
equivalent by any other nationally recognized rating agency.
· None
of the Company, any ERISA Affiliate nor any organization to which the Company
or
any ERISA Affiliate is a successor or parent corporation within the meaning
of
Section 4069(b) of ERISA has engaged in any transaction within the meaning
of
Section 4069 or 4212(c) of ERISA.
· There
are no pending actions, claims or lawsuits that have been asserted or instituted
against the Company Plans, the assets of any of the trusts under the Company
Plans or the sponsor or administrator of any of the Company Plans, or against
any fiduciary of the Company Plans with respect to the operation of any of
the
Company Plans (other than routine benefit claims), nor does the Company or
the
Selling Stockholders have any Knowledge of facts that could form the basis
for
any such claim or lawsuit.
· There
is no material violation of ERISA or the Code with respect to the filing of
applicable reports, documents and notices regarding the Company Plans with
the
Secretary of Labor or the Secretary of the Treasury or the furnishing of such
documents to the participants in or beneficiaries of the Company
Plans. All amendments and actions required to bring the Company Plans
into conformity in all material respects with all of the applicable provisions
of the Code, ERISA and other applicable Laws have been made or
taken. Any bonding required with respect to the Company Plans in
accordance with applicable provisions of ERISA has been obtained and is in
full
force and effect.
· Except
as set forth on Schedule 4.15(p), none of the Company Plans provides for
post-employment life or health insurance, benefits or coverage for any
participant or any beneficiary of a participant, except as may be required
under
the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended
(“COBRA”), and at the expense of the participant or the
participant’s beneficiary. Each of the Company and any ERISA
Affiliate
· which
maintains a “group health plan” within the meaning Section 5000(b)(1) of the
Code has complied with the notice and continuation requirements of Section
4980B
of the Code, COBRA, Part 6 of Subtitle B of Title I of ERISA and the regulations
thereunder.
· Neither
the execution and delivery of this Agreement nor the consummation of the
transactions contemplated hereby will (i) result in any payment becoming due
to
any Employee from the Company or any Subsidiary, (ii) increase any benefits
otherwise payable under any Company Plan or Title IV Plan or (iii) result in
the
acceleration of the time of payment or vesting of any such benefits under any
Company Plan or Title IV Plan.
· Neither
the Company nor any of the Subsidiaries has a contract, plan or commitment,
whether legally binding or not, to create any additional Company Plan or to
modify any existing Company Plan.
· No
stock or other security issued by the Company or any of the Subsidiaries forms
or has formed a material part of the assets of any Company Plan.
· Any
individual who performs services for the Company or any of the Subsidiaries
(other than through a contract with an organization other than such individual)
and who is not treated as an employee of the Company or any of the Subsidiaries
for Federal income tax purposes by the Company or any of the Subsidiaries is
not
an employee for such purposes.
1.34 Labor.
· Neither
the Company nor any of the Subsidiaries is a party to any labor or collective
bargaining agreement and there are no labor or collective bargaining agreements
which pertain to employees of the Company or any of the
Subsidiaries.
· No
Employees are represented by any labor organization. No labor
organization or group of Employees has made a pending demand for recognition,
and there are no representation proceedings or petitions seeking a
representation proceeding presently pending or, to the Knowledge of the Company
or the Selling Stockholders, threatened to be brought or filed, with the
National Labor Relations Board or other labor relations
tribunal. There is no organizing activity involving the Company or
any of the Subsidiaries pending or, to the Knowledge of the Company or the
Selling Stockholders, threatened by any labor organization or group of
Employees.
· There
are no (i) strikes, work stoppages, slowdowns, lockouts or arbitrations or
(ii) material grievances or other labor disputes pending or, to the
Knowledge of the Company or the Selling Stockholders, threatened against or
involving the Company or any of the Subsidiaries. There are no unfair
labor practice charges, grievances or complaints pending or, to the Knowledge
of
the Company or the Selling Stockholders, threatened by or on behalf of any
Employee or group of Employees.
· There
are no material complaints, charges or claims against the Company or any of
the
Subsidiaries pending or, to Knowledge of the Company or the Selling
Stockholders,
· threatened
that could be brought or filed, with any Governmental Body based on, arising
out
of, in connection with or otherwise relating to the employment or termination
of
employment of or failure to employ, any individual. Each of the
Company and the Subsidiaries is in material compliance with all Laws relating
to
the employment of labor, including all such Laws relating to wages, hours,
WARN
and any similar state or local “mass layoff” or “plant closing” Law, collective
bargaining, discrimination, civil rights, safety and health, workers’
compensation and the collection and payment of withholding and/or social
security taxes and any similar tax. There has been no “mass layoff”
or “plant closing” (as defined by WARN) with respect to the Company or any of
the Subsidiaries within the six (6) months prior to Closing.
1.35 Litigation. Except
as set forth in Schedule 4.17, there is no Legal Proceeding pending or,
to the Knowledge of the Company or the Selling Stockholders, threatened against
the Company or any of the Subsidiaries (or to the Knowledge of the Company
or
the Selling Stockholders, pending or threatened, against any of the officers,
directors or employees of the Company or any of the Subsidiaries with respect
to
their business activities on behalf of the Company), or to which the Company
or
any of the Subsidiaries is otherwise a party before any Governmental
Body. Except as set forth on Schedule 4.17, neither the
Company nor any Subsidiary is subject to any Order, and neither the Company
nor
any Subsidiary is in breach or violation of any Order. Except as set
forth on Schedule 4.17, neither the Company nor any Subsidiary is engaged
in any legal action to recover monies due it or for damages sustained by
it. There are no Legal Proceedings pending or, to the Knowledge of
the Company or the Selling Stockholders, threatened against the Company or
to
which the Company is otherwise a party relating to this Agreement or, any
Company Document or the transactions contemplated hereby or
thereby.
1.36 Compliance
with Laws; Permits.
· The
Company and the Subsidiaries are in compliance in all material respects with
all
Laws applicable to its business, operations or assets. Neither the
Company nor any Subsidiary has received any notice of or, to the Knowledge
of
the Company or the Selling Stockholders, been charged with the violation of
any
Laws. To the Knowledge of the Company or the Selling Stockholders,
neither the Company nor any Subsidiary is under investigation with respect
to
the violation of any Laws and there are no facts or circumstances which could
form the basis for any such violation.
· Schedule 4.18
contains a list of all Permits which are required for the operation of the
business of the Company and the Subsidiaries as presently conducted and as
presently intended to be conducted (“Company Permits”),
other than those the failure of which to possess is immaterial. The
Company and the Subsidiaries currently have all Permits which are required
for
the operation of their respective businesses as presently conducted and as
presently intended to be conducted, other than those the failure of which to
possess is immaterial. Neither the Company nor any Subsidiary is in
default or violation, and no event has occurred which, with notice or the lapse
of time or both, would constitute a default or violation, in any material
respect of any term, condition or provision of any Company Permit, and to the
Knowledge of the Company or the Selling Stockholders, there are no facts or
circumstances which could form the basis for any such default or
violation. There are no Legal Proceedings pending or, to
the
· Knowledge
of the Company or the Selling Stockholders, threatened, relating to the
suspension, revocation or modification of any Company
Permit. Assuming that the consents or waivers (as applicable) set
forth on Schedule 4.3 are obtained, none of the Company Permits will be
impaired or in any way affected by the consummation of the transactions
contemplated by this Agreement.
1.37 Environmental
Matters. Except as set forth on Schedule 4.19
hereto:
· the
operations of the Company and each of the Subsidiaries are and have been in
material compliance with all applicable Environmental Laws, which compliance
includes obtaining, maintaining in good standing and complying with all
Environmental Permits and no action or proceeding is pending or, to the
Knowledge of the Company or the Selling Stockholders, threatened to revoke,
modify or terminate any such Environmental Permit, and, to the Knowledge of
the
Company or the Selling Stockholders, no facts, circumstances or conditions
currently exist that could adversely affect such continued compliance with
Environmental Laws and Environmental Permits or require currently unbudgeted
capital expenditures to achieve or maintain such continued compliance with
Environmental Laws and Environmental Permits;
· neither
the Company nor any of the Subsidiaries is the subject of any outstanding
written Order or Contract with any Governmental Body or Person with respect
to
(i) Environmental Laws, (ii) Remedial Action or (iii) any Release or threatened
Release of a Hazardous Material;
· no
claim has been made or is pending or, to the Knowledge of the Company or the
Selling Stockholders, threatened against the Company or any Subsidiary alleging
either or both that the Company or any of the Subsidiaries may be in violation
of any Environmental Law or Environmental Permit or may have any material
liability under any Environmental Law;
· to
the Knowledge of the Company or the Selling Stockholders, no facts,
circumstances or conditions exist with respect to the Company or any of the
Subsidiaries or any property currently or formerly owned, operated or leased
by
the Company or any of the Subsidiaries or any property to which the Company
or
any of the Subsidiaries arranged for the disposal or treatment of Hazardous
Materials that could reasonably be expected to result in the Company or any
of
the Subsidiaries incurring material unbudgeted Environmental Costs and
Liabilities;
· there
are no investigations of the business or operations, currently or, to the
Knowledge of the Company or the Selling Stockholders, previously owned, operated
or leased property of the Company or any of the Subsidiaries pending or, to
the
Knowledge of the Company or the Selling Stockholders, threatened which could
lead to the imposition of any material Environmental Costs and Liabilities
or
Liens under Environmental Law;
· the
transactions contemplated hereunder do not require the consent of or filings
with any Governmental Body with jurisdiction over the Company or any Subsidiary
with respect to environmental matters;
· there
is not located at any of the properties currently or (while owned, operated
or
leased by the Company or any Subsidiary) previously owned, operated or leased
by
the Company or any of the Subsidiaries any (i) underground storage tanks, (ii)
landfill, (iii) surface impoundment, (iii) asbestos-containing material or
(iv)
equipment containing polychlorinated biphenyls; and
· the
Company has provided to Purchaser all environmentally related audits, studies,
reports, analyses, and results of investigations that have been performed by
or
on behalf of the Selling Stockholders, the Company or any of its Subsidiaries
with respect to the currently or previously owned, leased or operated properties
of the Company or any of the Subsidiaries.
1.38 Insurance. The
Company and the Subsidiaries have insurance policies in full force and effect
(a) for such amounts as are reasonable for all requirements of Law and all
agreements to which the Company or any of the Subsidiaries is a party or by
which it is bound, and (b) which are in such amounts, with such deductibles
and
against such risks and losses, as are reasonable for the business, assets and
properties of the Company and the Subsidiaries. Set forth in
Schedule 4.20 is a list of all insurance policies and all fidelity bonds
held by or applicable to the Company or any of the Subsidiaries setting forth,
in respect of each such policy, the policy name, policy number, carrier, term,
type and amount of coverage and annual premium, whether the policies may be
terminated upon consummation of the transactions contemplated hereby and if
and
to what extent events being notified to the insurer after the Closing Date
are
generally excluded from the scope of the respective policy. Except as
set forth on Schedule 4.20, no event relating to the Company or any of
the Subsidiaries has occurred which could reasonably be expected to result
in a
retroactive upward adjustment in premiums under any such insurance policies
or
which could reasonably be expected to result in a prospective upward adjustment
in such premiums. Excluding insurance policies that have expired and
been replaced in the Ordinary Course of Business, no insurance policy has been
cancelled within the last two years and, to the Knowledge of the Company or
the
Selling Stockholders, no threat has been made to cancel any insurance policy
of
the Company or any of the Subsidiaries during such period. Except as
noted on Schedule 4.20, all such insurance will remain in full force and
effect immediately following the consummation of the transactions contemplated
hereby. No event has occurred, including the failure by the Company
or any of the Subsidiaries to give any notice or information or the Company
or
any of the Subsidiaries giving any inaccurate or erroneous notice or
information, which limits or impairs the rights of the Company or any of the
Subsidiaries under any such insurance policies.
1.39 Inventories. Subject,
in each instance, to the effects of the proviso contained in the last
sentence of the first paragraph of Section 4.7(a): (a) the
inventories of the Company and the Subsidiaries are in good and marketable
condition, and are usable and of a quantity and quality saleable in the Ordinary
Course of Business; (b) the inventories of the Company and the Subsidiaries
set
forth in the Balance Sheet were valued at the lower of cost (on a FIFO/LIFO
basis) or market and were properly stated therein in accordance with GAAP
consistently applied; (c) adequate reserves have been reflected in the Balance
Sheet for obsolete, excess, damaged, slow-moving, or otherwise unusable
inventory, which reserves were calculated in a manner consistent with past
practice and in accordance with GAAP consistently applied; and (d) the
inventories of the Company and the Subsidiaries constitute sufficient quantities
for the normal operation of business in accordance with past
practice.
1.40 Accounts
and Notes Receivable and Payable
· Subject,
in each instance, to the effects of the proviso contained in the last
sentence of the first paragraph of Section 4.7(a): (i) all
accounts and notes receivable of the Company and the Subsidiaries have arisen
from bona fide transactions in the Ordinary Course of Business consistent with
past practice and are payable on ordinary trade terms; (ii) all accounts and
notes receivable of the Company and the Subsidiaries reflected on the Balance
Sheet are good and collectible at the aggregate recorded amounts thereof, net
of
any applicable reserve for returns or doubtful accounts reflected thereon,
which
reserves are adequate and were calculated in a manner consistent with past
practice and in accordance with GAAP consistently applied; (iii) all accounts
and notes receivable arising after the Balance Sheet Date are good and
collectible at the aggregate recorded amounts thereof, net of any applicable
reserve for returns or doubtful accounts, which reserves are adequate and were
calculated in a manner consistent with past practice and in accordance with
GAAP
consistently applied; and (iv) none of the accounts or the notes receivable
of
the Company or any of the Subsidiaries (A) are subject to any setoffs or
counterclaims or (B) represent obligations for goods sold on consignment, on
approval or on a sale-or-return basis or subject to any other repurchase or
return arrangement.
· All
accounts payable of the Company and the Subsidiaries reflected in the Balance
Sheet or arising after the date thereof are the result of bona fide transactions
in the Ordinary Course of Business and have been paid or are not yet due and
payable.
1.41 Related
Party Transactions. Except as set forth on Schedule 4.23,
no employee, officer, director, stockholder, partner or member of the Company
of
any of the Subsidiaries, any member of his or her immediate family or any of
their respective Affiliates (“Related Persons”) (i) owes
any amount to the Company or any of the Subsidiaries nor does the Company or
any
of the Subsidiaries owe any amount to, or has the Company or any of the
Subsidiaries committed to make any loan or extend or guarantee credit to or
for
the benefit of, any Related Person, (ii) is involved in any business arrangement
or other relationship with the Company or any of the Subsidiaries (whether
written or oral), (iii) owns any property or right, tangible or intangible,
that
is used by the Company or any of the Subsidiaries, (iv) has any claim or cause
of action against the Company or any of the Subsidiaries or (v) owns any direct
or indirect interest of any kind in, or controls or is a director, officer,
employee or partner of, or consultant to, or lender to or borrower from or
has
the right to participate in the profits of, any Person which is a competitor,
supplier, customer, landlord, tenant, creditor or debtor of the Company or
any
Subsidiary.
1.42 Customers
and Suppliers.
· Schedule
4.24(a) sets forth a list of the thirty (30) largest customers and the ten
(10) largest suppliers of the Company and the Subsidiaries, as measured by
the
dollar amount of purchases therefrom or thereby, during each of the fiscal
years
ended December 31, 2006 and 2005, showing the approximate total sales by the
Company and the Subsidiaries to each such customer and the approximate total
purchases by the Company and the Subsidiaries from each such supplier, during
such period.
· Except
as set forth on Schedule 4.24(b), since the Balance Sheet Date, no
customer or supplier listed on Schedule 4.24(a) has terminated its
relationship with the Company or any of the Subsidiaries or materially reduced
or changed the pricing or other terms of its business with the Company or any
of
the Subsidiaries and, to the Knowledge of the Company or the Selling
Stockholders, no customer or supplier listed on Schedule 4.24(a) has
notified the Company or the Subsidiaries that it intends to terminate or
materially reduce or change the pricing or other terms of its business with
the
Company or any of the Subsidiaries.
1.43 Product
Warranty; Product Liability.
· To
the Knowledge of the Company and the Selling Stockholders, each product
manufactured, sold or delivered by the Company or any of the Subsidiaries in
conducting its business has been in material conformity with all product
specifications, all express and implied warranties and all applicable
Laws. Neither the Company nor any of the Subsidiaries has any
material liability for replacement or repair of any such products or other
damages in connection therewith or any other customer or product obligations
not
reserved against on the Balance Sheet.
· Neither
the Company nor any of the Subsidiaries has any material liability arising
out
of any injury to individuals or property as a result of the ownership,
possession, or use of any product designed, manufactured, assembled, repaired,
maintained, delivered, sold or installed, or services rendered, by or on behalf
of the Company or any of the Subsidiaries. Neither the Company nor
any of the Subsidiaries has committed any act or failed to commit any act,
which
would result in, and there has been no occurrence which would give rise to
or
form the basis of, any material product liability or liability for breach of
warranty (whether covered by insurance or not) on the part of the Company or
any
of the Subsidiaries with respect to products designed, manufactured, assembled,
repaired, maintained, delivered, sold or installed or services rendered by
or an
behalf of the Company or any of the Subsidiaries.
1.44 Banks;
Power of Attorney. Schedule 4.26 contains a complete and
correct list of the names and locations of all banks in which the Company or
any
Subsidiary has accounts or safe deposit boxes and the names of all persons
authorized to draw thereon or to have access thereto. Except as set
forth on Schedule 4.26, no person holds a power of attorney to act on
behalf of the Company or any Subsidiary.
1.45 Certain
Payments. To the Knowledge of the Company or the Selling
Stockholders, none of the Company, any Subsidiary or any Selling Stockholder
or
any director, officer, employee, or other Person associated with or acting
on
behalf of any of them, has directly or indirectly (a) made in violation of
any
Law any contribution, gift, bribe, rebate, payoff, influence payment, kickback,
or other payment to any Person, private or public, regardless of form, whether
in money, property, or services (i) to obtain favorable treatment in securing
business for the Company or any Subsidiary, (ii) to pay for favorable treatment
for business secured by the Company or any Subsidiary, (iii) to obtain special
concessions or for special concessions already obtained, for or in respect
of
the Company or any Subsidiary, or (b) established or maintained any fund or
asset with respect to the Company or any Subsidiary that has not be recorded
in
the books and records of the Company and the Subsidiaries.
1.46 Certain
Governmental Matters. Neither the Company nor any Subsidiary has
received from any U.S. Governmental Body or any prime contractor or
subcontractor from a U.S. Governmental Body any special, preferential or
advantageous treatment in the award of a Government Contract, or in any other
manner, including as a “small business concern,” “small disadvantaged business”
(or “minority-owned business”), “women-owned” concern, or any other socially and
economically disadvantaged classification, as defined in the Small Business
Act
(15 U.S.C. Sec. 631, et. seq.), the Federal Property and Administrative Services
Act (41 U.S.C. Sec. 252), section 7102 of the Federal Acquisition Streamlining
Act of 1994 (Public Law 103-355), 10 U.S.C. Sec 2323, Executive Order 12138,
May
18, 1979, or regulations implementing these requirements, including the Federal
Acquisition Regulations. “Government
Contract” means any prime contract with a U.S. Governmental Body
and any subcontract with a prime contractor or higher tier subcontractor under
a
prime contract with a U.S. Governmental Body.
1.47 Financial
Advisors. Except as set forth on Schedule 4.29, no Person
has acted, directly or indirectly, as a broker, finder or financial advisor
for
the Company or any Subsidiary in connection with the transactions contemplated
by this Agreement. On and after the Closing Date, none of the
Company, its Subsidiaries, Purchaser or any other Purchaser Indemnified Party
is
or will be obligated or liable for the payment of any fee or commission or
like
payment in respect of any broker, finder or financial advisor for the Company
or
any Subsidiary in connection with the transactions contemplated by this
Agreement.
REPRESENTATIONS
AND WARRANTIES OF PURCHASER
Purchaser
hereby represents and warrants to the Selling Stockholders that:
1.48 Organization
and Good Standing. Purchaser is a corporation duly organized,
validly existing and in good standing under the laws of the State of Texas
and
has all requisite corporate power and authority to own, lease and operate
properties and carry on its business.
1.49 Authorization
of Agreement. Purchaser has full corporate power and authority to
execute and deliver this Agreement and each other agreement, document,
instrument or certificate contemplated by this Agreement or to be executed
by
Purchaser in connection with the consummation of the transactions contemplated
hereby and thereby (the “Purchaser Documents”), and to
consummate the transactions contemplated hereby and thereby. The
execution, delivery and performance by Purchaser of this Agreement and each
Purchaser Document have been duly authorized by all necessary corporate action
on behalf of Purchaser. This Agreement has been, and each Purchaser
Document will be at or prior to the Closing, duly executed and delivered by
Purchaser and (assuming the due authorization, execution and delivery by the
other parties hereto and thereto) this Agreement constitutes, and each Purchaser
Document when so executed and delivered will constitute, the legal, valid and
binding obligation of Purchaser, enforceable against Purchaser in accordance
with its respective terms.
1.50 Conflicts;
Consents of Third Parties.
· None
of the execution and delivery by Purchaser of this Agreement and of the
Purchaser Documents, the consummation of the transactions contemplated hereby
or
thereby, or compliance by Purchaser with any of the provisions hereof or thereof
will conflict with, or result in violation or breach of, conflict with or
default (with or without notice or lapse of time, or both) under, or give rise
to a right of termination, cancellation or acceleration of any
obligation under any provision of (i) the certificate of incorporation and
by-laws or comparable organizational documents of such Purchaser; (ii) any
Contract, or Permit to which Purchaser is a party or by which any of the
properties or assets of Purchaser are bound; (iii) any Order of any Governmental
Body applicable to Purchaser or by which any of the properties or assets of
Purchaser are bound; or (iv) any applicable Law.
· No
consent, waiver, approval, Order, Permit or authorization of, or declaration
or
filing with, or notification to, any Person or Governmental Body is required
on
the part of Purchaser in connection with the execution and delivery of this
Agreement or the Purchaser Documents or the compliance by Purchaser with any
of
the provisions hereof or thereof, except for compliance with the applicable
requirements of the HSR Act.
1.51 Litigation. There
are no Legal Proceedings pending or, to the Knowledge of Purchaser, threatened
against Purchaser or to which Purchaser is otherwise a party relating to this
Agreement, the Purchaser Documents or the transactions contemplated hereby
and
thereby.
1.52 Investment
Intention. Purchaser is acquiring the Shares for its own account,
for investment purposes only and not with a view to the distribution (as such
term is used in Section 2(11) of the Securities Act
thereof. Purchaser understands that the Shares have not been
registered under the Securities Act and cannot be sold unless subsequently
registered under the Securities Act or an exemption from such registration
is
available.
1.53 Financial
Advisors. Except for Xxxxxxxx, Inc., no Person has acted,
directly or indirectly, as a broker, finder or financial advisor for Purchaser
in connection with the transactions contemplated by this Agreement and no Person
is entitled to any fee or commission or like payment in respect
thereof.
1.54 Financing. Schedule
5.7 sets forth complete and correct copies of firm commitment letters from
the financial institutions signatories thereto for the debt financing to be
used
in connection with the transactions contemplated hereby (the
“Financing”). The amount of the Financing,
together with other financing to be provided by Purchaser, will provide
sufficient funds for Purchaser to consummate the transactions contemplated
by
this Agreement.
COVENANTS
1.55 Access
to Information; Confidentiality. The Company shall, and the
Company shall cause the Subsidiaries to, afford to Purchaser and its
accountants, counsel, financial advisors and other representatives, and to
prospective lenders and other financing
1.56 sources
and each of their respective representatives, access, during normal business
hours upon reasonable notice throughout the period prior to the Closing, to
the
Company’s and the Subsidiaries’ respective properties and facilities (including
all owned or leased real property and the buildings, structures, fixtures,
appurtenances and improvements erected, attached or located thereon), books,
financial information (including working papers and data in the possession
of
the Company’s or the Subsidiaries’ or their respective independent public
accountants, internal audit reports, and “management letters” from such
accountants with respect to the Company’s or any of the Subsidiaries’ systems of
internal control), Contracts and records of the Company and the Subsidiaries
and, during such period, shall furnish promptly such information concerning
the
businesses, properties and personnel of the Company and the Subsidiaries as
Purchaser shall reasonably request; provided, however, such
investigation shall not unreasonably disrupt the Company’s
operations. Prior to the Closing, the Company shall generally keep
Purchaser informed as to all material matters involving the operations and
businesses of the Company and each of the Subsidiaries. The Company
shall authorize and direct the appropriate directors, managers and employees
of
each such Subsidiary to discuss matters involving the operations and business
of
the Company or such Subsidiary, as the case may be, with representatives of
Purchaser and its prospective lenders or placement agents and other financial
sources. All nonpublic information provided to, or obtained by,
Purchaser in connection with the transactions contemplated hereby shall be
“Confidential Information” for purposes of (a) the Confidentiality Agreement
dated January 9, 2007 among Purchaser and the Company, (b) the Non-Disclosure
Non-Use and Confidentiality Agreement dated March 21, 2007 among Purchaser
and
the Company and certain of their Affiliates and certain representative persons
thereof, and (c) the Mutual Non-Disclosure Agreement dated June 13, 2007 among
Purchaser and the Company (collectively, the “Confidentiality
Agreement”), the terms of which shall continue in force until the
Closing; provided that Purchaser and the Company may disclose such
information as may be necessary in connection with seeking necessary consents
and approvals as contemplated hereby. Notwithstanding the foregoing,
the Company and the Subsidiaries shall not be required to disclose any
information if such disclosure would contravene any applicable Law.
1.57 Conduct
of the Business Pending the Closing.
· Except
as otherwise expressly provided in this Agreement or with the prior written
consent of Purchaser, between the date hereof and the Closing, the Selling
Stockholders and the Company shall, and the Company shall cause the Subsidiaries
to:
· conduct
the respective businesses of the Company and the Subsidiaries only in the
Ordinary Course of Business;
· use
their commercially reasonable efforts to (A) preserve the present business
operations, organization (including officers and employees) and goodwill of
the
Company and the Subsidiaries and (B) preserve the present relationships with
Persons having business dealings with the Company and the Subsidiaries
(including customers and suppliers);
· maintain
(A) all of the assets and properties of, or used by, the Company and the
Subsidiaries in their current condition, ordinary wear and tear excepted, and
(B)
· insurance
upon all of the properties and assets of the Company and the Subsidiaries in
such amounts and of such kinds comparable to that in effect on the date of
this
Agreement;
· (A)
maintain the books, accounts and records of the Company and the Subsidiaries
in
the Ordinary Course of Business, (B) continue to collect accounts
receivable and pay accounts payable utilizing normal procedures and without
discounting or accelerating payment of such accounts, and (C) comply in all
material respects with all contractual and other obligations of the Company
and
the Subsidiaries;
· comply
with the capital expenditure plan of the Company and the Subsidiaries for the
current fiscal year, including making such capital expenditures in the amounts
and at the times set forth in such plan; and
· comply
in all material respects with all applicable Laws.
· Without
limiting the generality of the foregoing, except as otherwise expressly provided
in this Agreement or with the prior written consent of Purchaser, the Selling
Stockholders and the Company shall not, and the Company shall cause the
Subsidiaries not to:
· declare,
set aside, make or pay any dividend or other distribution in respect of the
capital stock of, or other ownership interests in, the Company or any of the
Subsidiaries or repurchase, redeem or otherwise acquire any outstanding shares
of the capital stock or other securities of, or other ownership interests in,
the Company or any of the Subsidiaries;
· transfer,
issue, sell, pledge, encumber or dispose of any shares of capital stock or
other
securities of, or other ownership interests in, the Company or any of the
Subsidiaries or grant options, warrants, calls or other rights to purchase
or
otherwise acquire shares of the capital stock or other securities of, or other
ownership interests in, the Company or any of the
Subsidiaries;
· effect
any recapitalization, reclassification, stock split, combination or like change
in the capitalization of the Company or any of the Subsidiaries, or amend the
terms of any outstanding securities of the Company or any
Subsidiary;
· amend
the certificate of incorporation or by-laws or equivalent organizational or
governing documents of the Company or any of the Subsidiaries;
· except
in the Ordinary Course of Business, (A) increase the salary or other
compensation of any director, officer or employee of the Company or any of
the
Subsidiaries, (B) grant any unusual or extraordinary bonus, benefit or other
direct or indirect compensation to any director, officer, employee or
consultant, (C) increase the coverage or benefits available under any (or create
any new) severance pay, termination pay, vacation pay, company awards, salary
continuation for disability, sick leave, deferred compensation, bonus or other
incentive compensation, insurance, pension or other employee benefit plan or
arrangement made to, for, or with any of the directors,
· officers,
employees, agents or representatives of the Company or any of the Subsidiaries
or otherwise modify or amend or terminate any such plan or arrangement or
(D) enter into any employment, deferred compensation, severance, special
pay, consulting, non-competition or similar agreement or arrangement with any
directors or officers of the Company or any Subsidiary (or amend any such
agreement to which the Company or any of the Subsidiaries is a
party);
· issue,
create, incur, assume, guarantee, endorse or otherwise become liable or
responsible with respect to (whether directly, contingently or otherwise) any
Indebtedness; pay, repay, discharge, purchase, repurchase or satisfy any
Indebtedness of the Company or any of the Subsidiaries, except in the Ordinary
Course of Business; or modify the terms of any Indebtedness or other
Liability;
· subject
to any Lien or otherwise encumber or, except for Permitted Exceptions, permit,
allow or suffer to be encumbered, any of the properties or assets (whether
tangible or intangible) of, or used by, the Company or any of the
Subsidiaries;
· acquire
any material properties or assets or sell, assign, license, transfer, convey,
lease or otherwise dispose of any of the material properties or assets of,
or
used by, the Company and the Subsidiaries, other than in the Ordinary Course
of
Business;
· enter
into or agree to enter into any merger or consolidation with any corporation
or
other entity; or engage in any new business or invest in, make a loan, advance
or capital contribution to, or otherwise acquire the securities, of any other
Person;
· cancel
or compromise any debt or claim or waive or release any material right of the
Company or any of the Subsidiaries except in the Ordinary Course of
Business;
· enter
into any commitment for capital expenditures of the Company and the Subsidiaries
in excess of $50,000 for any individual commitment and $250,000 for all
commitments in the aggregate;
· enter
into, modify or terminate any labor or collective bargaining agreement of the
Company or any of the Subsidiaries or, through negotiation or otherwise, make
any commitment or incur any liability to any labor organization with respect
to
the Company or any of the Subsidiaries;
· introduce
any material change with respect to the operation of the Company or any of
the
Subsidiaries, including any material change in the types, nature, composition
or
quality of its products or services, or, other than in the Ordinary Course
of
Business, make any change in product specifications or prices or terms of
distributions of such products or change its pricing, discount, allowance or
return policies or grant any pricing, discount, allowance or return terms for
any customer or supplier not in accordance with such policies;
· except
for transfers of cash pursuant to normal cash management practices in the
Ordinary Course of Business, make any investments in or loans to, or pay any
fees or expenses to, or enter into or modify any Contract with any Related
Persons;
· make
a change in its accounting or Tax reporting principles, methods or
policies;
· (A)
make, change or revoke any Tax election, settle or compromise any Tax claim
or
liability or enter into a settlement or compromise, or change (or make a request
to any taxing authority to change) any material aspect of its method of
accounting for Tax purposes, or (B) prepare or file any Tax Return (or any
amendment thereof) unless such Tax Return shall have been prepared in a manner
consistent with past practice and the Company shall have provided Purchaser
a
copy thereof (together with supporting papers) at least three Business Days
prior to the due date thereof for Purchaser to review and approve (such approval
not to be unreasonably withheld or delayed);
· enter
into any Contract, understanding or commitment that restrains, restricts, limits
or impedes the ability of the Company or any Subsidiary to compete with or
conduct any business or line of business in any geographic area or solicit
the
employment of any persons;
· terminate,
amend, restate, supplement or waive any rights under any (A) Material Contract,
Real Property Lease, Personal Property Lease or Intellectual Property License,
other than in the Ordinary Course of Business or (B) Permit;
· settle
or compromise any pending or threatened Legal Proceeding or any claim or claims
for, or that would result in a loss of revenue of, an amount that could,
individually or in the aggregate, reasonably be expected to be greater than
$150,000;
· change
or modify its credit, collection or payment policies, procedures or practices,
including acceleration of collections or receivables (whether or not past due)
or fail to pay or delay payment of payables or other liabilities;
· take
any action which would adversely affect the ability of the parties to consummate
the transactions contemplated by this Agreement;
· agree
to do anything (A) prohibited by this Section 6.2, (B) which would make
any of the representations and warranties of the Selling Stockholders in this
Agreement or any of the Selling Stockholder Documents or Company Documents
untrue or incorrect in any material respect or could result in any of the
conditions to the Closing not being satisfied or (C) that would be reasonably
expected to have a Material Adverse Effect; and
· fail
to pay any required maintenance or other similar fees or otherwise fail to
make
required filings or payments required to maintain and further prosecute any
applications for registration of Intellectual Property.
· Notwithstanding
any of the foregoing terms of this Section 6.2 or any other terms and
provisions of this Agreement to the contrary, on or prior to the Closing, the
Company shall sell, transfer, assign, convey or otherwise deliver those assets
identified on Schedule 6.2 hereto (the “Distributable
Assets”) to the Selling Stockholders or such other Person(s) as
they may choose and such actions (subject to their being taken in the manner
described in this Section 6.2) shall not cause a failure of any of the
representations and warranties made by the Selling Stockholders in this
Agreement or any Selling Stockholder Document or Company to be true and correct
or otherwise constitute a breach of any other covenant or other agreement on
the
part of the Company or the Selling Stockholders pursuant to this
Agreement. The sale, transfer, assignment, conveyance or other
delivery of the Distributable Assets shall in any event be pursuant to
agreements, instruments and other documentation in form and substance reasonably
acceptable to Purchaser, including, without limitation, that, other than as
specifically identified on Schedule 6.2, none of the Company, its
Subsidiaries or any Purchaser Indemnified Parties shall retain or otherwise
be
responsible or obligated for any Liabilities relating to any of the
Distributable Assets (including any thereof based upon, attributable to or
resulting from the Company’s or an applicable Subsidiary’s maintenance,
operation and ownership of any such Distributable Assets prior to such sale,
transfer, assignment, conveyance or other delivery).
1.58 Third
Party Consents. The Selling Stockholders and the Company shall
use, and the Company shall cause the Subsidiaries to use, their commercially
reasonable efforts to obtain at the earliest practicable date all consents,
waivers and approvals from, and provide all notices to, all Persons that are
not
a Governmental Body, which consents, waivers, approvals and notices are required
to consummate, or in connection with, the transactions contemplated by this
Agreement, including the consents, waivers, approvals and notices referred
to in
Sections 3.3(b) and 4.3(b) hereof (except for such matters covered
by Section 6.4). All such consents, waivers, approvals and
notices shall be in writing and in form and substance satisfactory to Purchaser,
and executed counterparts of such consents, waivers and approvals shall be
delivered to Purchaser promptly after receipt thereof, and copies of such
notices shall be delivered to Purchaser promptly after the making
thereof. Notwithstanding anything to the contrary in this Agreement,
neither Purchaser nor any of its Affiliates (which for purposes of this sentence
shall include the Company) shall be required to pay any amounts in connection
with obtaining any such consent, waiver or approval.
1.59 Governmental
Consents and Approvals.
· Each
of Purchaser, the Selling Stockholders and the Company shall use, and the
Company shall cause each of the Subsidiaries to use, its commercially reasonable
efforts to obtain at the earliest practical date all consents, waivers,
approvals, Orders, Permits, authorizations and declarations from,
make all filings with, and provide all notices to, all Governmental Bodies
which
are required to consummate, or in connection with, the transactions contemplated
by this Agreement, including the consents, waivers, approvals, Orders, Permits,
authorizations, declarations, filings and notices referred to in Sections
3.3(b), 4.3(b) and 5.3(b). Without limiting the
foregoing, Purchaser, Selling Stockholders and the Company shall (i) make all
filings required of each of them or any of their respective Subsidiaries or
Affiliates under the HSR Act or other Antitrust Laws with respect to the
transactions contemplated hereby as
· promptly
as practicable and, in any event, within three (3) Business Days after the
date
of this Agreement in the case of all filings required under the HSR Act, (ii)
comply at the earliest practicable date with any request under the HSR Act
for
additional information, documents, or other materials received by each of them
or any of their respective Subsidiaries or Affiliates from the U.S. Federal
Trade Commission (the “FTC”), the Antitrust Division of
the U.S. Department of Justice (the “Antitrust
Division”) or any other Governmental Body in respect of such
filings or such transactions, and (iii) cooperate with each other in connection
with any such filing (including, to the extent permitted by applicable Law,
providing copies of all such documents to the non-filing parties prior to filing
and considering all reasonable additions, deletions or changes suggested in
connection therewith) and in connection with resolving any investigation or
other inquiry of any of the FTC, the Antitrust Division or other Governmental
Body under any Antitrust Laws with respect to any such filing or any such
transaction. Each such party shall use commercially reasonable
efforts to furnish to each other party hereto all information required for
any
application or other filing to be made pursuant to any applicable Law in
connection with the transactions contemplated by this Agreement. Each
such party shall promptly inform the other parties hereto of any oral
communication with, and provide copies of written communications with, any
Governmental Body regarding any such filings or any such transaction and permit
the other party to review in advance any proposed communication by such party
to
any Governmental Body. No party hereto shall independently
participate in any formal meeting with any Governmental Body in respect of
any
such filings, investigation, or other inquiry without giving the other parties
hereto prior notice of the meeting and, to the extent permitted by such
Governmental Body, the opportunity to attend and/or
participate. Subject to applicable Law, the parties hereto shall
consult and cooperate with one another in connection with the matters described
in this Section 6.4, including in connection with any analyses,
appearances, presentations, memoranda, briefs, arguments, opinions and proposals
made or submitted by or on behalf of any party hereto relating to proceedings
under the HSR Act or other Antitrust Laws.
· Each
of Purchaser, the Selling Stockholders and the Company shall use commercially
reasonable efforts to resolve such objections, if any, as may be asserted by
any
Governmental Body with respect to the transactions contemplated by this
Agreement under any Law, including the HSR Act, the Xxxxxxx Act, as amended,
the
Xxxxxxx Act, as amended, the Federal Trade Commission Act, as amended, and
any
other Laws that are designed to prohibit, restrict or regulate actions having
the purpose or effect of monopolization or restraint of trade (collectively,
the
“Antitrust Laws”). In connection therewith,
if any Legal Proceeding is instituted (or threatened to be instituted)
challenging any transaction contemplated by this Agreement as in violation
of
any Law, the Selling Stockholders and the Company shall use commercially
reasonable efforts, and Purchaser shall cooperate with the Selling Stockholders
and the Company, to contest and resist any such Legal Proceeding, and to have
vacated, lifted, reversed, or overturned any decree, judgment, injunction or
other order whether temporary, preliminary or permanent, that is in effect
and
that prohibits, prevents, or restricts consummation of the transactions
contemplated by this Agreement, including by pursuing all available avenues
of
administrative and judicial appeal unless, by mutual agreement, Purchaser and
the Selling Stockholders decide that litigation is not in their respective
best
interests. Each of Purchaser, the Selling Stockholders and the
Company shall use commercially reasonable efforts to take such action as may
be
required to cause the expiration of the notice periods under the HSR Act
or
· other
Antitrust Laws with respect to such transactions as promptly as possible after
the execution of this Agreement. Notwithstanding anything to the
contrary in this Agreement, neither Purchaser nor any of its Affiliates (which
for purposes of this sentence shall include the Company) shall be required,
in
connection with the matters covered by this Section 6.4, (i) to pay any
amounts (other than the payment of filing fees and expenses and fees of
counsel), (ii) to commence or defend any litigation, (iii) to hold separate
(including by trust or otherwise) or divest any of their respective businesses,
product lines or assets, (iv) to agree to any limitation on the operation or
conduct of their or the Company’s or any of the Subsidiaries’ respective
businesses or (v) to waive any of the conditions set forth in Article VII
of this Agreement. Purchaser shall pay the fees associated with
filings required by the HSR Act.
1.60 Further
Assurances. Subject to, and not in limitation of,
Section 6.4, each of the Selling Stockholders, the Company and
Purchaser shall use its commercially reasonable efforts to (a) take, or cause
to
be taken, all actions necessary or appropriate to consummate the transactions
contemplated by this Agreement and (b) cause the fulfillment at the earliest
practicable date of all of the conditions to their respective obligations to
consummate the transactions contemplated by this Agreement.
1.61 No
Shop.
· The
Selling Stockholders and the Company shall not, and shall not permit the
Subsidiaries or any of the Affiliates, directors, officers, employees,
representatives or agents of the Selling Stockholders, the Company or any of
the
Subsidiaries (collectively, the “Representatives”) to,
directly or indirectly, (i) discuss, encourage, negotiate, undertake,
initiate, authorize, recommend, propose or enter into, whether as the proposed
surviving, merged, acquiring or acquired corporation or otherwise, any
transaction involving a merger, consolidation, business combination, purchase
or
disposition of any material amount of the assets of the Company or any of the
Subsidiaries or any capital stock or other ownership interests of the Company
or
any of the Subsidiaries other than the transactions contemplated by this
Agreement (an “Acquisition Transaction”),
(ii) facilitate, encourage, solicit or initiate discussions, negotiations
or submissions of proposals or offers in respect of an Acquisition Transaction,
(iii) furnish or cause to be furnished, to any Person, any information
concerning the business, operations, properties or assets of the Company or
the
Subsidiaries in connection with an Acquisition Transaction, or
(iv) otherwise cooperate in any way with, or assist or participate in,
facilitate or encourage, any effort or attempt by any other Person to do or
seek
any of the foregoing.
· The
Selling Stockholders and the Company shall (and the Selling Stockholders and
the
Company shall cause their Representatives to, and the Company shall cause the
Subsidiaries and their Representatives to) immediately cease and cause to be
terminated any existing discussions or negotiations with any Persons (other
than
Purchaser) conducted heretofore with respect to any Acquisition
Transaction. The Selling Stockholders and the Company agree not to
(and the Company agrees to cause the Subsidiaries not to) release any third
party from the confidentiality and standstill provisions of any agreement to
which the Company or any of the Subsidiaries is a party.
1.62 Non-Competition;
Non-Solicitation; Confidentiality.
1.63 In
consideration of Purchaser’s purchase of the goodwill and business relationships
of the Company and its Subsidiaries hereunder, for a period of three (3) years
from and after the Closing Date, the Selling Stockholders shall not, and shall
cause their Affiliates not to, directly or indirectly, own, manage, engage
in,
operate, control, work for, consult with, maintain any interest in (proprietary,
financial or otherwise) or participate in the ownership, management, operation
or control of, any business, whether in corporate, proprietorship or partnership
form or otherwise, engaging in the Territory in a business the same or similar
to that, or that otherwise competes with, Purchaser, the Company or any of
the
Subsidiaries (a “Restricted Business”); provided,
however, that the restrictions contained
in this
Section 6.7(a) shall not restrict (i) the acquisition by the Selling
Stockholders, directly or indirectly, of less than two percent (2%) of the
outstanding capital stock of any publicly traded company engaged in a Restricted
Business and (ii) the business and activities of the trustee of the Trust other
than solely those business and activities engaged in on behalf of the
Trust. The automated payment processing and cash flow management
system business of CFO-PE Strategies, LLC, and incidental activities relating
thereto, as engaged in as of the date hereof, shall not constitute a Restricted
Business; provided, however, that the foregoing shall not permit
CFO-PE Strategies, LLC to engage in business (other than in Canada, which shall
be excluded from the Territory for this purpose) with (A) the industrial
distribution companies that have over ninety percent (90%) of their aggregate
business and operations or revenues in supplying the following industrial
products: bearings and power transmission, pumps, pipes, valves and
fittings, fluid power, rubber belts and hoses; or (B) those supply chain service
businesses listed on Schedule 6.7(a).
· Additionally,
in consideration of Purchaser’s purchase of the goodwill and business
relationships of the Company and its Subsidiaries hereunder, for a period of
three (3) years from and after the Closing Date, the Selling Stockholders shall
not, and shall cause their directors, officers and Affiliates not to, directly
or indirectly: (i) cause, solicit, induce or encourage any
employees of Purchaser, the Company or the Subsidiaries to leave such employment
or (ii) cause, induce or encourage any material actual or prospective
client, customer, supplier, or licensor of Purchaser, the Company or any of
the
Subsidiaries (including any existing or former customer of the Company or the
Subsidiaries and any Person that becomes a client or customer of Purchaser,
the
Company or any of the Subsidiaries after the Closing) or any other Person who
has a material business relationship with Purchaser, the Company or any of
the
Subsidiaries, to terminate or modify any such actual or prospective
relationship.
· From
and after the Closing Date, the Selling Stockholders shall not and shall cause
their directors, officers and Affiliates not to, directly or indirectly,
disclose, reveal, divulge or communicate to any Person other than authorized
officers, directors and employees of Purchaser or use or otherwise exploit
for
its own benefit or for the benefit of anyone other than Purchaser, any
Confidential Information (as defined below). The Selling Stockholders
shall not have any obligation to keep confidential (or cause its officers,
directors or Affiliates to keep confidential) any Confidential Information
if
and to the extent disclosure thereof is specifically required by applicable
Law;
provided, however, that in the event disclosure is required by
applicable Law, the Selling Stockholders shall, to the extent reasonably
possible, provide Purchaser with prompt notice of such requirement prior to
making any disclosure so that Purchaser may seek an appropriate protective
order. For purposes of this Section 6.7(c),
“Confidential Information” means any information with
respect to Purchaser, the Company or
· any
of the Subsidiaries, including methods of operation, customer lists, products,
prices, fees, costs, Technology, inventions, trade secrets, know-how, Software,
marketing methods, plans, personnel, suppliers, competitors, markets or other
specialized information or proprietary
matters. “Confidential Information” does not
include, and there shall be no obligation hereunder with respect to, information
that (i) is generally available to the public on the date of this Agreement,
(ii) becomes generally available to the public other than as a result of a
disclosure not otherwise permissible hereunder, (iii) is or has been
independently developed by a Selling Stockholder or an Affiliate without use
or
reference to or other derivation from any Confidential Information, or (iv)
refers to Purchaser, the Company or any of the Subsidiaries as customers of
CFO-PE Strategies, LLC or that provides historical information of benefits
or
services CFO-PE Strategies, LLC has provided them (or makes them available
as a
customer reference thereof), provided, however, that such
information does not disclose or make reference to any customers or suppliers
relationships of Purchaser, the Company and any of the Subsidiaries and of
Confidential Information relating to any such customer or supplier
relationships.
· The
covenants and undertakings contained in this Section 6.7 relate to
matters which are of a special, unique and extraordinary character and a
violation of any of the terms of this Section 6.7 will cause
irreparable injury to Purchaser, the Company or its Subsidiaries (as
applicable), the amount of which will be impossible to estimate or determine
and
which cannot be adequately compensated. Accordingly, the remedy at
law for any breach of this Section 6.7 will be
inadequate. Therefore, Purchaser and the Company will be entitled to
a temporary and permanent injunction, restraining order or other equitable
relief from any court of competent jurisdiction in the event of any breach
of
this Section 6.7 without the necessity of proving actual damage or
posting any bond whatsoever. The rights and remedies provided by this
Section 6.7 are cumulative and in addition to any other rights and
remedies which Purchaser may have hereunder or at law or in
equity. In the event that Purchaser were to seek damages for any
breach of this Section 6.7, the portion of the consideration
delivered to the Selling Stockholders hereunder which is allocated by the
parties to the foregoing covenant shall not be considered a measure of or limit
on such damages.
· The
parties hereto agree that, if any court of competent jurisdiction determines
that a specified time period, a specified geographical area, a specified
business limitation or any other relevant feature of this Section 6.7 is
unreasonable, arbitrary or against public policy, then a lesser period of time,
geographical area, business limitation or other relevant feature which is
determined by such court to be reasonable, not arbitrary and not against public
policy may be enforced against the applicable party.
1.64 Preservation
of Records. Subject to any retention requirements relating to the
preservation of Tax records, the Selling Stockholders and Purchaser agree that
each of them shall (and Purchaser shall cause the Company and the Subsidiaries
to) preserve and keep the records held by them on the date of this Agreement
relating to the respective businesses of the Company and the Subsidiaries for
a
period of seven (7) years from the Closing Date and shall make such records
and
personnel available to the other as may be reasonably required by such party
in
connection with, among other things, any insurance claims by, legal proceedings
against or governmental investigations of the Selling Stockholders, the Company,
the Subsidiaries or Purchaser or any of their Affiliates or in order to enable
the Selling Stockholders or Purchaser to
1.65 comply
with their respective obligations under this Agreement and each other agreement,
document or instrument contemplated hereby or thereby.
1.66 Publicity.
· None
of the Purchaser, Selling Stockholders or the Company shall issue any press
release or public announcement concerning this Agreement or the transactions
contemplated hereby without obtaining the prior written approval of the other
party hereto, which approval will not be unreasonably withheld or delayed,
unless, in the sole judgment of Purchaser, disclosure is otherwise required
by
applicable Law or by the applicable rules of any stock exchange on which
Purchaser or its Affiliates lists securities, provided that, to the
extent required by applicable Law, the party intending to make such release
shall use its commercially reasonable efforts consistent with such applicable
Law to consult with the other party with respect to the text
thereof.
· Each
of Purchaser, the Selling Stockholders and the Company agrees that the terms
of
this Agreement shall not be disclosed or otherwise made available to the public
and that copies of this Agreement shall not be publicly filed or otherwise
made
available to the public, except where such disclosure, availability or filing
is
required by applicable Law and only to the extent required by such
Law.
1.67 Environmental
Matters.
· The
Company shall permit Purchaser and Purchaser's environmental consultant, to
conduct such additional investigations (including investigations known as “Phase
I” and “Phase II” environmental Site Assessments) of the environmental
conditions of any real property owned, operated or leased by or for the Company
or any Subsidiary and the operations conducted thereat (subject to any
limitations contained in valid, previously executed leases) as Purchaser, in
its
reasonable discretion, shall deem necessary (“Purchaser's
Environmental Assessment”). Purchaser
acknowledges that it has used commercially reasonable efforts to complete the
Purchaser’s Environmental Assessment prior to the date hereof and agrees that
any further investigations from and after the date hereof shall be limited
to
those that the Purchaser believes absolutely are necessary. Purchaser
agrees that any such remaining investigation as part of Purchaser’s
Environmental Assessment shall be conducted by a qualified environmental
consulting firm, possessing reasonable levels of insurance, in compliance with
applicable Laws and in a manner that minimizes the disruption of the operations
of the Company.
· The
Company shall promptly file all materials required by Environmental Laws as
a
result of or in furtherance of the transaction contemplated hereunder, including
any notifications or approvals required under environmental property transfer
laws, and all requests required or necessary for the transfer or re-issuance
of
Environmental Permits required to conduct the Company’s
business. Purchaser shall cooperate in all reasonable respects with
the Company with respect to such filings.
1.68 Cooperation
with Financing. In order to assist with obtaining the Financing,
the Selling Stockholders and the Company shall, and the Company shall cause
the
Subsidiaries to, provide such assistance and cooperation as Purchaser may
reasonably request,
1.69 including
(i) cooperating with prospective lenders and their respective advisors in
performing their due diligence and (ii) helping procure other definitive
financing documents or other reasonably requested certificates or documents
at
Purchaser’s cost.
1.70 Related-Party
Transactions with Non-Management Affiliates. On or prior to the
Closing Date, the Company and the Subsidiaries shall (a) terminate all Contracts
with any of the Selling Stockholders or their respective Affiliates (other
than
(i) those Contracts set forth on Schedule 6.12 and (ii) Contracts between
the Company and the Subsidiaries, Contracts between the Company and the
Subsidiaries and their respective officers and employees and Contracts the
continuation of which Purchaser has approved in writing) and (b) deliver
releases executed by such Affiliates with whom the Company has terminated such
Contracts pursuant to this Section 6.12 providing that no further
payments are due, or may become due, under or in respect of any such terminated
Contacts; provided that in no event shall the Company or any of the
Subsidiaries pay any fee or otherwise incur any expense or financial exposure
with respect to any such termination or release.
1.71 Monthly
Financial Statements. As soon as reasonably practicable, but in
no event later than twenty (20) days after the end of each calendar month during
the period from the date hereof to the Closing, the Company shall provide
Purchaser with (a) unaudited monthly financial statements and (b) operating
or
management reports (such reports to be in the form prepared by the Company
in
the Ordinary Course of Business) of the Company for such preceding
month. As soon as reasonably practicable, but in no event later than
twenty (20) days after the end of each calendar month, during the period from
the date hereof to the Closing, the Company shall provide Purchaser with (i)
unaudited monthly financial statements and (ii) operating or management reports
(such reports to be in the form prepared by the Company and the Subsidiaries
in
the Ordinary Course of Business) of each of the Subsidiaries for which financial
statements are prepared (to the extent the same are prepared in the Ordinary
Course of Business) for such preceding month.
1.72 Employee
Matters. From and after the date hereof, and after the Closing
Date Purchaser shall cause, the Company and its Subsidiaries to retain their
current employees subject, except with respect to those employees that are
executive officers of the Company and its Subsidiaries, to the discretion of
the
Company’s president and chief financial officer (including from and after the
Closing Date when Purchaser has purchased the Company and its Subsidiaries
pursuant hereto), and the employment of such employees shall be on terms and
conditions, including in respect of benefits and other compensation programs,
no
less favorable, in the aggregate, than as those that the Company and its
Subsidiaries provides as of the date hereof; the retained employees shall not
be
required to complete any additional pre-employment screening or testing as
a
condition of continued employment as of the Closing with the Company or its
Subsidiaries; provided, however, that the foregoing shall not
change the “at-will” condition of employment generally of such employees or
limit Purchaser’s, the Company’s or any applicable Subsidiary’s ability to
conduct random drug testing of the retained employees. If, in the
future, Purchaser determines that the employees of the Company and its
Subsidiaries should be transferred from the employee benefit programs maintained
by the Company and its Subsidiaries to those provided or otherwise maintained
by
Purchaser generally for its employees (other than those that may have been
previously provided or maintained generally for the employees of the Company
and
its Subsidiaries), then Purchaser shall provide such employee
1.73 benefits
that are no less favorable, in the aggregate, than those provided and maintained
by the Company and its Subsidiaries for such employees as of the date hereof
and
shall, for purposes of eligibility, vesting and levels of benefits under any
such employee benefit programs of Purchaser, credit each such employee with
his
or her years of service with the Company and its Subsidiaries to the same extent
as such employee was entitled under those employee benefit programs maintained
by the Company and its Subsidiaries for such employees as of the date
hereof. Additionally, any such employee benefit programs provided or
otherwise maintained by Purchaser generally for its employees to which Purchaser
transfers the employees of the Company and its Subsidiaries (if any transfer
shall occur) shall not deny such employees coverage on the basis of pre-existing
conditions (and shall not require any conditional screening or testing for
purposes thereof) and shall credit such transferred employees for any
deductibles and out-of-pocket expenses paid in the year of such transfer in
the
employee benefit programs of the Company and its Subsidiaries.
1.74 Notification
of Certain Matters. The Selling Stockholders shall give notice to
Purchaser and Purchaser shall give notice to the Selling Stockholders, as
promptly as reasonably practicable upon becoming aware of (a) any fact, change,
condition, circumstance, event, occurrence or non-occurrence that has caused
or
is reasonably likely to cause any representation or warranty in this Agreement
made by it to be untrue or inaccurate in any material respect at any time after
the date hereof and prior to the Closing, (b) any material failure on its part
to comply with or satisfy any covenant, condition or agreement to be complied
with or satisfied by it hereunder or (c) the institution of or the threat of
institution of any Legal Proceeding against any of the Selling Stockholders,
the
Company or any of the Subsidiaries related to this Agreement or the transactions
contemplated hereby; provided that the delivery of any notice pursuant to
this Section 6.15 shall not limit or otherwise affect the remedies
available hereunder to the party receiving such notice, or the representations
or warranties of, or the conditions to the obligations of, the parties
hereto.
1.75 Debt. No
later than the third Business Day prior to the Closing Date, the Company shall
provide Purchaser with (i) a certificate of the Company setting forth an
estimate of the balance of all Indebtedness of the Company and the Subsidiaries
as of the close of business on the day immediately preceding the Closing Date
and (ii) customary pay-off letters from all holders of Indebtedness to be repaid
as of or prior to the Closing. The Company shall also make
arrangements reasonably satisfactory to Purchaser for such holders to provide
to
Purchaser recordable form mortgage and lien releases, canceled notes and other
documents reasonably requested by Purchaser prior to the Closing such that
all
Liens on the assets or properties of the Company or any of the Subsidiaries
that
are not Permitted Exceptions shall be satisfied, terminated and discharged
on or
prior to the Closing Date. On the Closing Date prior to the Closing,
the Company shall deliver to Purchaser a certificate of the Company setting
forth all Indebtedness of the Company and the Subsidiaries as of the close
of
business on the day immediately preceding the Closing Date.
1.76 Resignation
of Directors. The Selling Stockholders shall cause each of the
directors of the Company and the Subsidiaries to submit a letter of resignation
effective on or before the Closing Date.
1.77 Nomination
of Director for Purchaser Board. Upon consummation of the
Closing, Purchaser shall use reasonable efforts to appoint a person named by
the
Controlling Owner to the Board of Directors of Purchaser; provided,
however, that such right and appointment of such person named by the
Controlling Owner shall be subject to (a) the rules and requirements of
applicable Law as well as the rules and regulation promulgated by the United
States Securities and Exchange Commission and by any other self-regulatory
organization applicable to Purchaser’s securities and governance obligations in
respect thereof and (b) such person’s meeting the applicable requirements for
serving on Purchaser’s Board of Directors (whether under Purchaser’s
organizational documents or applicable Law, including the rules and regulations
noted under clause (a)). In recognition of such foregoing provision,
Purchaser shall undertake to have liability coverage under Purchaser’s director
and office insurance policy as set forth on Schedule 6.18.
CONDITIONS
TO CLOSING
1.78 Conditions
Precedent to Obligations of Purchaser. The obligation of
Purchaser to consummate the transactions contemplated by this Agreement is
subject to the fulfillment, on or prior to the Closing Date, of each of the
following conditions precedent (any or all of which may be waived by Purchaser
in whole or in part to the extent permitted by applicable Law):
· the
representations and warranties of the Selling Stockholders qualified as to
materiality shall be true and correct, and those not so qualified shall be
true
and correct in all material respects as of the Closing as though made at and
as
of the Closing, except to the extent such representations and warranties
expressly speak as of an earlier date (in which case such representations and
warranties qualified as to materiality shall be true and correct, and those
not
so qualified shall be true and correct in all material respects, on and as
of
such earlier date);
· the
Selling Stockholders and the Company shall have performed and complied in all
material respects with all obligations and agreements required in this Agreement
to be performed or complied with by them on or prior to the Closing
Date;
· there
shall not have been or occurred any event, change, occurrence or circumstance
that, individually or in the aggregate with any such events, changes,
occurrences or circumstances, has had or could reasonably be expected to have
a
Material Adverse Effect since the date of this Agreement;
· there
shall not be in effect any Order by a Governmental Body of competent
jurisdiction restraining, enjoining or otherwise prohibiting the consummation
of
the transactions contemplated hereby;
· Purchaser
shall have received (i) a certificate signed by the Stockholder Representative,
for and on behalf of each of the Selling Stockholders and (ii) a certificate
signed by each of the chief executive officer, chief operating officer and
chief
financial officer of the Company, each in form and substance reasonably
satisfactory to Purchaser, dated the Closing
· Date,
to the effect that each of the conditions specified above in Sections
7.1(a)-(d) have been satisfied in all respects; provided
that with respect to Section 7.1(a), the chief executive officer, chief
operating officer and chief financial officer of the Company shall only be
required to certify as to the representations and warranties contained in
Article IV;
· the
waiting period under the HSR Act shall have expired or early termination shall
have been granted;
· the
Selling Stockholders and the Company shall have obtained those consents,
approvals, orders and authorizations, the issuance, reissuance and transfer
of
Permits, and made the registrations, declarations and filings listed on
Schedule 7.1(g) in a form satisfactory to Purchaser and copies thereof
shall have been delivered to Purchaser;
· Purchaser
shall have received the written resignations and release of claims to fees
or
expenses of each of the directors and officers of the Company and the
Subsidiaries identified by Purchaser prior to Closing, each in form and
substance reasonably satisfactory to Purchaser;
· each
of the employment agreements of Xxxxxxxxxxx X. Xxxxx, as the Company’s
president, and Xxxxx Xxxxxxx, as its chief financial officer, dated as of the
date hereof to be effective upon the Closing Date (and set forth in Schedule
7.1(i)), shall be (subject only to such condition of effectiveness) in full
force and effect;
· all
stock or other outstanding equity interests in Subsidiaries of the Company
or
any of the Company’s Subsidiaries not owned by the Company or such Subsidiary as
of the date hereof (including, without limitation, with respect to Precision
de
Mexico) shall have been transferred to Purchaser (or as directed by Purchaser),
free and clear of all Liens;
· [omitted];
· Purchaser
shall have received any material items listed in Sections 2.5 and 2.6 (and,
for
purposes hereof, any items that are required for delivery by Purchaser or the
Company as a condition to closing the Financing shall be deemed to be
material);
· the
Stockholder Representative and the Escrow Agent shall have entered into and
executed the Escrow Agreement, substantially in the form of Exhibit B
hereto;
· the
Controlling Owner shall have entered into and executed an Access Agreement,
substantially in the form of Exhibit C hereto;
· the
sale, transfer, assignment, conveyance or other delivery of the Distributable
Assets in accordance with Section 6.2(c) shall be pursuant to agreements,
instruments and other documentation in form and substance reasonably acceptable
to Purchaser;
· the
Company and Controlling Owner or the applicable Affiliates or Related Persons
thereof shall have entered into and executed leases (or other lease
documentation) for the facilities of the Company and its Subsidiaries listed
on
Schedule 7.1(p)
· hereto,
in each case subject to the basic terms and provisions as described on
Schedule 7.1(p) and otherwise in form and substance reasonably acceptable
to Purchaser, and each of the Affiliates or Related Persons (as applicable)
of
the Company and the Subsidiaries that leases real property to the Company or
a
Subsidiary (as applicable) shall have executed and delivered a form of release
document, dated as of the Closing Date and substantially in the form included
with Schedule 7.1(p) hereto, regarding each such leased
property;
· (i)
Neterprise, Inc., an Affiliate of the Controlling Owner, shall have entered
into
and executed an amendment to the Software License Agreement, dated and effective
July 22, 1999, with the Company, substantially in the form included in
Schedule 7.1(q), with the Company, and (ii) CFO-PE Strategies, LLC,
another Affiliate of the Controlling Owner, shall have entered into and executed
a technology license agreement, substantially in the form also included in
Schedule 7.1(q), with Purchaser and, subject to the payment by Purchaser
for the license under clause (ii) at the time of Closing, such agreements shall
be in full force and effect; and
· Purchaser
shall have received written evidence, in the form and substance provided by
Purchaser to Controlling Owner on or prior to the date hereof, that the Selling
Stockholders and their Affiliates have irrevocably and unconditionally released
the Company and the Subsidiaries from any and all Liabilities to the Selling
Stockholders and their Affiliates (other than pursuant to arrangements as
specifically contemplated by the terms and conditions hereof).
1.79 Conditions
Precedent to Obligations of the Selling Stockholders. The
obligations of the Selling Stockholders to consummate the transactions
contemplated by this Agreement are subject to the fulfillment, prior to or
on
the Closing Date, of each of the following conditions precedent (any or all
of
which may be waived by the Selling Stockholders in whole or in part to the
extent permitted by applicable Law):
· the
representations and warranties of Purchaser set forth in this Agreement
qualified as to materially shall be true and correct, and those not so qualified
shall be true and correct in all material respects as of the Closing as though
made at and as of the Closing, except to the extent such representations and
warranties expressly relate to an earlier date (in which case such
representations and warranties qualified as to materially shall be true and
correct, and those not so qualified shall be true and correct in all material
respects, on and as of such earlier date);
· Purchaser
shall have performed and complied in all material respects with all obligations
and agreements required by this Agreement to be performed or complied with
by
Purchaser on or prior to the Closing Date;
· there
shall not be in effect any Order by a Governmental Body of competent
jurisdiction restraining, enjoining or otherwise prohibiting the consummation
of
the transactions contemplated hereby;
· Purchaser
and the Escrow Agent shall have entered into and executed the Escrow Agreement,
substantially in the form of Exhibit B hereto;
· the
Selling Stockholders shall have obtained those, consents, approvals, orders,
authorizations, the issuance, reissuance and transfer of Permits, and made
the
registrations, declarations and filings listed on Schedule
7.2(e);
· Purchaser
and the Company shall have entered into and executed an Access Agreement,
substantially in the form of Exhibit C hereto; and
· the
waiting period under the HSR Act shall have expired or early termination shall
have been granted and Purchaser shall have obtained or made any other consent,
approval, order or authorization of, or registration, declaration or filing
with, any Governmental Body required to be obtained or made by it in connection
with the execution and delivery of this Agreement or the consummation of the
transactions contemplated hereby.
INDEMNIFICATION
1.80 Survival
of Provisions.
· The
representations and warranties of the parties contained in this Agreement,
any
certificate delivered pursuant hereto or any Selling Stockholder Document,
Company Document or Purchaser Document shall survive the Closing through and
including the first (1st) anniversary of the Closing Date; provided,
however, that the representations and warranties set forth in Sections
3.1 (Organization), 3.2 (Authorization), 3.4 (Ownership),
3.6 (Financial Advisors), 4.1 (Organization), 4.2
(Authorization), 4.4 (Capitalization), 4.5 (Subsidiaries),
4.10 (Taxes), 4.29 (Financial Advisors), 5.1
(Organization), 5.2 (Authorization) and 5.6 (Financial Advisors)
shall survive the Closing until 90 days following the expiration of the
applicable statute of limitations with respect to the particular matter that
is
the subject matter thereof (in each case, the “Survival
Period”).
· No
claim for a breach of a Pre-Closing Covenant may be made or brought by any
party
hereto after the first (1st) anniversary
of
the Closing Date.
· Notwithstanding
any of the foregoing provisions to the contrary, the obligations for
indemnification as provided under Section 8.2 shall not terminate with
respect to any Losses as to which the Person to be indemnified shall have given
notice (stating in reasonable detail the basis of the claim for indemnification)
to the indemnifying party in accordance with Section 8.3 before the
termination of the applicable Survival Period.
1.81 Indemnification.
· Subject
to Sections 8.1, 8.4 and 8.5 hereof, the Selling
Stockholders hereby agree, jointly and severally (except as provided in
Section 8.4(d)), to indemnify and hold Purchaser, the Company, and their
respective directors, officers, employees, Affiliates, stockholders, agents,
attorneys, representatives, successors and assigns (collectively, the
“Purchaser Indemnified Parties”) harmless from and
against, and pay to the applicable Purchaser Indemnified Parties the amount
of,
any and all losses, liabilities, claims, obligations,
· deficiencies,
demands, judgments, damages, interest, fines, penalties, claims, suits, actions,
causes of action, assessments, awards, costs and expenses (including attorneys’
and other professionals’ fees), whether or not involving a third party claim
(individually, a “Loss” and, collectively,
“Losses”):
· based
upon, attributable to or resulting from the failure of any of the
representations and warranties made by the Selling Stockholders in this
Agreement to be true and correct at of the date hereof and at and as of the
Closing Date;
· based
upon, attributable to or resulting from the breach of any Pre-Closing Covenant
on the part of the Company or any Selling Stockholders;
· based
upon, attributable to or resulting from the breach of any covenant or other
agreement under Sections 2.7, 2.8, 6.7, 6.8,
6.9, 9.3, Article X and this Article VIII, as well
as those covenants and agreements related to certain state tax matters set
forth
in Schedule 4.10(a) and relating to certain federal and state tax matters
set forth in Schedule 6.2, on the part of the Selling Stockholders under
this Agreement;
· arising
from or related to (A) any Company Transaction Expenses (to the extent and
only
if any such Company Transaction Expenses (I) are an obligation or Liability
of a
Purchaser Indemnified Party after the Closing and (II) are not included in
Included Current Liabilities for purposes of calculation of the Closing Working
Capital and, thus, not incorporated into the adjustment as provided under
Section 2.7) or (B) Indebtedness of the Company or any of its
Subsidiaries, in each case to the extent not paid by the Selling Stockholders
or
the Company or the Subsidiaries prior to the Closing or paid contemporaneously
with the Closing; and
· based
upon, attributable to or resulting from any Legal Proceeding that on or prior
to
the Closing Date shall have been instituted against the Selling Stockholders,
the Company or any of the Subsidiaries, or Purchaser, seeking to restrain or
prohibit or obtain substantial damages with respect to the consummation of
the
transactions contemplated by this Agreement.
· Subject
to Sections 8.1, 8.4 and 8.5 hereof, Purchaser hereby
agrees to indemnify and hold the Selling Stockholders and their respective
Affiliates, stockholders, agents, attorneys, representatives, successors and
permitted assigns (collectively, the “Selling Stockholder Indemnified
Parties”) harmless from and against, and pay to the applicable
Selling Stockholder Indemnified Parties the amount of any and all
Losses:
· based
upon, attributable to or resulting from the failure of any of the
representations or warranties made by Purchaser in this Agreement to be true
and
correct at the date hereof and as of the Closing Date;
· based
upon, attributable to or resulting from the breach of any covenant or other
agreement on the part of Purchaser under this Agreement.
· The
waiver of any condition based on the accuracy of any such representation or
warranty, or on the performance of or compliance with any such covenant or
agreements, will not affect the right to indemnification or any other remedy
based on such representations, warranties, covenants and
agreements.
1.82 Indemnification
Procedures.
· A
claim for indemnification for any matter not involving a third party claim
may
be asserted by notice to the party from whom indemnification is sought;
provided, however, that failure to so notify the indemnifying
shall not preclude the indemnified party from any indemnification which it
may
claim in accordance with this Article VIII.
· In
the event that any Legal Proceedings shall be instituted or that any claim
or
demand shall be asserted by any third party in respect of which indemnification
may be sought under Section 8.2 hereof (regardless of the limitations set
forth in Section 8.4) (a “Third Party Claim”),
the indemnified party shall promptly cause written notice of the assertion
of
any Third Party Claim of which it has knowledge which is covered by this
indemnity to be forwarded to the indemnifying party. The failure of
the indemnified party to give reasonably prompt notice of any Third Party Claim
shall not release, waive or otherwise affect the indemnifying party’s
obligations with respect thereto except to the extent that the indemnifying
party can demonstrate actual loss and prejudice as a result of such
failure. Subject to the provisions of this Section 8.3,
the indemnifying party shall have the right, at its sole expense, to be
represented by counsel of its choice, which must be reasonably satisfactory
to
the indemnified party, and to defend against, negotiate, settle or otherwise
deal with any Third Party Claim which relates to any Losses indemnified against
hereunder; provided that the indemnifying party shall have acknowledged
in writing to the indemnified party its unqualified obligation (subject to
the
limitations of Section 8.4) to indemnify the indemnified party as
provided hereunder. If the indemnifying party elects to defend
against, negotiate, settle or otherwise deal with any Third Party Claim which
relates to any Losses indemnified by it hereunder, it shall within five days
of
the indemnified party’s written notice of the assertion of such Third Party
Claim (or sooner, if the nature of the Third Party Claim so requires) notify
the
indemnified party of its intent to do so; provided, that the indemnifying
party must conduct the defense of the Third Party Claim actively and diligently
thereafter in order to preserve its rights in this regard. If the
indemnifying party elects not to defend against, negotiate, settle or otherwise
deal with any Third Party Claim which relates to any Losses indemnified against
hereunder, fails to notify the indemnified party of its election as herein
provided or contests its obligation to indemnify the indemnified party for
such
Losses under this Agreement, the indemnified party may defend against,
negotiate, settle or otherwise deal with such Third Party Claim. If
the indemnified party defends any Third Party Claim, then the indemnifying
party
shall reimburse the indemnified party for the expenses of defending such Third
Party Claim upon submission of periodic bills. If the indemnifying
party shall assume the defense of any Third Party Claim, the indemnified party
may participate, at his or its own expense, in the defense of such Third Party
Claim; provided, however, that such indemnified party shall be
entitled to participate in any such defense with separate counsel at the expense
of the indemnifying party if (i) so requested by the indemnifying party to
participate or (ii) in the reasonable opinion of counsel to the indemnified
party, a conflict or potential conflict exists between the indemnified party
and
the indemnifying party that would make such separate representation advisable;
and provided, further, that the indemnifying party shall not be
required
· to
pay for more than one such counsel for all indemnified parties in connection
with any Third Party Claim. The parties hereto agree to provide
reasonable access to the other to such documents and information as may be
reasonably requested in connection with the defense, negotiation or settlement
of any such Third Party Claim. Notwithstanding anything in this
Section 8.3 to the contrary, neither the indemnifying party nor the
indemnified party shall, without the written consent of the other party, settle
or compromise any Third Party Claim or permit a default or consent to entry
of
any judgment unless the claimant or claimants and such party provide to such
other party an unqualified release from all liability in respect of the Third
Party Claim. If the indemnifying party makes any payment on any Third
Party Claim, the indemnifying party shall be subrogated, to the extent of such
payment, to all rights and remedies of the indemnified party to any insurance
benefits or other claims of the indemnified party with respect to such Third
Party Claim.
· After
any final decision, judgment or award shall have been rendered by a Governmental
Body of competent jurisdiction and the expiration of the time in which to appeal
therefrom, or a settlement shall have been consummated, or the indemnified
party
(or the Stockholder Representative, in the case of a claim for indemnification
for which payment may be sought under Section 8.2(b), and the
indemnifying party (or, in the case of a claim for indemnification for which
payment may be sought under Section 8.2(a), the Stockholder
Representative) shall have arrived at a mutually binding agreement with respect
to a claim for indemnification hereunder, the indemnified party (or, as
applicable, the Stockholder Representative) shall forward to the indemnifying
party (or, in the case of a claim for indemnification for which payment may
be
sought under Section 8.2(a), the Stockholder Representative) notice of
any sums due and owing by the indemnifying party pursuant to this Agreement
with
respect to such matter.
· Following
the determination of any applicable amount that the Selling Stockholders shall
be obligated to indemnify pursuant to Section 8.2(a)(i) or
8.2(a)(ii), the Stockholder Representative shall (i) promptly direct,
in
accordance with Section 8.6, the Escrow Agent to distribute to the
applicable Purchaser Indemnified Party such amount in satisfaction of such
obligations and (ii) to the extent such applicable amounts are not within the
Cap but are properly payable pursuant to Sections 8.2 and 8.4,
notify the Selling Stockholders so that payment may be made to the applicable
Purchaser Indemnified Party by each such Selling Stockholder in satisfaction
of
its respective obligations under Section 8.2(a).
1.83 Limitations
on Indemnification.
(a) An
indemnifying party shall not have any liability under Section 8.2(a)(i)
hereof unless the aggregate amount of Losses incurred by the indemnified parties
and indemnifiable thereunder based upon, attributable to or resulting from
the
failure of any of the representations or warranties to be true and correct
exceeds $1,000,000 (the “Rep Basket”) and, in such
event, the indemnifying party shall be required to pay only the amount of such
Losses in excess of $250,000 (the “Rep Deductible”);
provided that the Rep Basket and Rep Deductible limitations
shall not
apply to Losses related to breaches of representations and warranties as set
forth in Sections 3.1 (Organization), 3.2 (Authorization),
3.4 (Ownership), 3.6 (Financial Advisors), 4.1
(Organization), 4.2 (Authorization), 4.4 (Capitalization),
4.5 (Subsidiaries), 4.10 (Taxes) and 4.29
(Financial Advisors).
(b) The
Selling Stockholders shall not have any liability for indemnification under
Section 8.2(a)(ii) hereof unless the aggregate amount of Losses incurred
by Purchaser Indemnified Parties and indemnifiable thereunder based upon,
attributable to or resulting from the breach of any Pre-Closing Covenant on
the
part of the Company or any Selling Stockholders exceeds $100,000 (the
“Covenant Basket”) and, in such event the Selling
Stockholders shall be required to pay the amount of such Losses only to the
extent of such excess. Notwithstanding any of the foregoing
provisions to the contrary, to the extent that any liability for indemnification
by the Selling Stockholders based upon, attributable to or resulting from a
breach of a Pre-Closing Covenant on the part of the Company or any Selling
Stockholders is also covered under this Agreement under indemnification
obligations of the Selling Stockholders relating to a breach of a representation
or warranty of the Selling Stockholders, then such liability shall be deemed
to
arise and be incurred pursuant to Section 8.2(a)(i) and, thus, be subject
to the Rep Basket and Rep Deductible for purposes of the limitations set forth
in this Section 8.4.
(a) The
Selling Stockholders shall not be required to indemnify any Person under
Sections 8.2(a)(i) and 8.2(a)(ii) for an aggregate amount of
Losses exceeding an amount equal to $5,000,000 of the Purchase Price (the
“Cap”); provided that there shall be no Cap with
respect to Losses related to breaches of any representations or warranties
contained in Sections 3.1 (Organization), 3.2 (Authorization),
3.4 (Ownership), 3.6 (Financial Advisors), 4.1
(Organization), 4.2 (Authorization), 4.4 (Capitalization),
4.5 (Subsidiaries), 4.10 (Taxes) and 4.29 (Financial
Advisors) of this Agreement.
(b) Notwithstanding
anything herein to the contrary, (i) no Selling Stockholder, other than the
Controlling Owner, shall be liable for indemnification obligations in an amount
in excess of its respective portion of the Purchase Price received (or, in
respect of the Indemnity Escrow Amount, receivable) pursuant hereto and (ii)
the
Trust shall have no liability for indemnification obligations
hereunder
(c) The
amount of any Losses for which indemnification is provided under this Article
VIII shall be net of any (i) amounts actually recovered by the indemnified
party pursuant to any indemnification by or indemnification or other agreement
with any third party or (ii) insurance proceeds or other cash receipts or
sources of reimbursement actually received (in each case, net of any costs
of
collection or increased premiums relating thereto); provided,
however, that clause (ii) shall apply only if the effect of such
provision does not constitute an impermissible waiver of the insurer’s rights of
subrogation against the indemnifying party. The parties acknowledge
and agree that nothing in this Section 8.4(e) shall (i) create an
obligation of any party to maintain any form or level of insurance or other
arrangements after the Closing, (ii) name any other party as an additional
indemnitee, insured or other party or (iii) obtain approval for any waiver
of
rights of subrogation.
(d) For
purposes of calculating Losses hereunder, any materiality or Material Adverse
Effect qualifications in the representations, warranties, covenants and
agreements shall be disregarded.
(e) The
Selling Stockholders shall have no right of contribution or other recourse
against the Company or the Subsidiaries or their respective directors, officers,
employees, Affiliates, agents, attorneys, representatives, assigns or successors
for any Third
(f) Party
Claims asserted by Purchaser Indemnified Parties, it being acknowledged and
agreed that the covenants and agreements of the Company are solely for the
benefit of the Purchaser Indemnified Parties.
1.84 Tax
Matters.
· Tax
Indemnification. The Selling Stockholders hereby agree to be
liable for and to indemnify and hold the Purchaser Indemnified Parties harmless
from and against, and pay to the Purchaser Indemnified Parties the amount of,
any and all Losses respect of (i) all Taxes of the Company and the Subsidiaries
(or any predecessor thereof) (A) for any taxable period ending on or before
the
Closing Date, and (B) for the portion of any Straddle Period ending at the
close
of business on the Closing Date (determined as provided in Section
8.5(d)); (ii) any and all Taxes imposed on any member of a consolidated,
combined or unitary group of which the Company or any Subsidiary (or any
predecessor thereof) is or was a member on or prior to the Closing Date, by
reason of the liability of the Company or any Subsidiary (or any predecessor
thereof), pursuant to Treasury Regulation Section 1.1502-6(a) (or any
predecessor or successor thereof or any analogous or similar provision under
state, local or foreign Law); (iii) the failure of any of the representations
and warranties contained in Section 4.10 to be true and correct in all
respects or the failure to perform any covenant contained in this Agreement
with
respect to Taxes; (iv) any recapture of Nebraska LB 775 tax credits from the
Company due to the failure to meet or maintain the requirements of LB 775 prior
to the Closing Date; and (v) any Taxes resulting from, arising out of or based
on the Section 338(h)(10) Election (as defined in Section
8.5(b)).
· 338(h)(10)
Election.
· The
Selling Stockholders shall join with Purchaser in making an election under
Section 338(h)(10) of the Code and the Treasury Regulations and any
corresponding or similar elections under state, local or foreign tax law
(collectively, the “Section 338(h)(10) Election”) with
respect to the Company and each of the Subsidiaries. For the purpose
of making the Section 338(h)(10) Election for federal income Tax purposes,
on or
prior to the Closing Date, the Selling Stockholders shall deliver to Purchaser
an executed original IRS Form 8023 (or successor form). If no Section
338(h)(10) Election is to be made, the Form 8023 will be returned to the Selling
Stockholders within 120 days after the Closing Date. If a Section
338(h)(10) Election is to be made, Purchaser will file the Form 8023 with the
IRS. At least 30 days prior to the due date of such form Purchaser
will provide the Stockholder Representative a copy of the proposed Form 8023
and
all attachments thereto and Purchaser shall negotiate in good faith with the
Stockholder Representative concerning any reasonable adjustments
thereto.
· Purchaser
shall be responsible for the preparation and filing of all forms and documents
required to effectuate the Section 338(h)(10) Election. In addition
to the Form 8023, the Selling Stockholders shall execute (or cause to be
executed) and deliver to Purchaser such additional documents or forms as are
reasonably requested to complete properly the Section 338(h)(10) Election at
least 15 days prior to the date such Section 338(h)(10) Election is required
to
be filed.
· Purchaser
and the Selling Stockholders shall file, and shall cause their Affiliates to
file, all Tax Returns and statements, form and schedules in connection therewith
in a manner consistent with the Section 338(h)(10) Election and shall take
no
position contrary thereto unless required to do so by applicable Tax
Laws.
· If
Purchaser notifies the Selling Stockholders of its intent to make a Section
338(h)(10) Election, the allocation statement set forth on Schedule
8.5(b) (the “Allocation Statement”), which allocates
the Purchase Price and any other items that are treated as additional Purchase
Price for tax purposes among the Company and the Subsidiaries and among the
different items of assets of the Company and the Subsidiaries, shall be
applicable. All Tax Returns and reports filed by Purchaser, the
Selling Stockholders and their respective Affiliates shall be prepared
consistently with such Allocation Statement.
· Filing
of Tax Returns; Payment of Taxes.
· The
Company shall (and shall cause the Subsidiaries to) timely file all Tax Returns
required to be filed by it on or prior to the Closing Date and shall pay or
cause to be paid all Taxes shown due thereon. All such Tax Returns
shall be prepared in all material respects in a manner consistent with prior
practice. The Company shall provide Purchaser with copies of such
completed Tax Returns at least twenty (20) days prior to the due date for filing
thereof, along with supporting workpapers, for Purchaser’s review and
approval. The Selling Stockholders and Purchaser shall attempt in
good faith to resolve any disagreements regarding such Tax Returns prior to
the
due date for filing. In the event that the Selling Stockholders and
the Purchaser are unable to resolve any dispute with respect to such Tax Return
at least ten days prior to the due date for filing, such dispute shall be
resolved pursuant to Section 8.5(g), which resolution shall be binding on
the parties.
· Following
the Closing, Purchaser shall cause to be timely filed all Tax Returns required
to be filed by the Company and the Subsidiaries after the Closing Date and,
subject to the rights to payment from the Selling Stockholders under
Section 8.5(c)(iii), pay or cause to be paid all Taxes shown due
thereon; provided that, if an applicable Tax Return sets forth Taxes for
which the Selling Stockholders are responsible (including, without limitation,
as an indemnification obligation under this Section 8.5) then Purchaser
shall provide a copy of such Tax Return to the Stockholder Representative at
least ten (10) days prior to filing and shall negotiate in good faith with
the
Stockholder Representative concerning any reasonable adjustments
thereto.
· Not
later than ten (10) days prior to the due date for the payment of Taxes on
any
Tax Returns which Purchaser has the responsibility to cause to be filed pursuant
to Section 8.5(c)(ii), the Selling Stockholders shall pay to Purchaser or
the applicable Governmental Body the amount of Taxes, as reasonably determined
by Purchaser, owed by the Selling Stockholders pursuant to the provisions of
Section 8.5(a). No payment pursuant to this
Section 8.5(c)(iii) shall excuse the Selling Stockholders from its
indemnification obligations pursuant to Section 8.5(a) if the amount of
Taxes as ultimately determined (on audit or otherwise) for the periods covered
by such Tax
· Returns
exceeds the amount of the Selling Stockholders’ payment under this Section
8.5(c)(iii)
· Straddle
Period Tax Allocation. The Company will, unless prohibited by
applicable Law, close the taxable period of the Company and the Subsidiaries
as
of the close of business on the Closing Date. If applicable Law does
not permit the Company or a Subsidiary to close its taxable year on the Closing
Date or in any case in which a Tax is assessed with respect to a taxable period
which includes the Closing Date (but does not begin or end on that day) (a
“Straddle Period”), the Taxes, if any, attributable to a
Straddle Period shall be allocated (i) to the Selling Stockholders for the
period up to and including the close of business on the day immediately
preceding the Closing Date and (ii) to Purchaser for the period subsequent
to
the day immediately preceding the Closing Date; provided, however,
that such allocation shall in no way affect the obligation of the Selling
Stockholders to be responsible and liable for any and all Taxes (including,
without limitation, arising out of or based on the Section 338(h)(10) Election)
relating to the consummation of the transactions under this Agreement, other
than such Taxes for which Purchaser is responsible as set forth under Section
8.5(f) hereof. Any allocation of income or deductions required to
determine any Taxes attributable to a Straddle Period shall be made by means
of
a closing of the books and records of the Company and the Subsidiaries as of
the
close of the Closing Date, provided that exemptions, allowances or
deductions that are calculated on an annual basis (including, but not limited
to, depreciation and amortization deductions) shall be allocated between the
period ending on the Closing Date and the period after the Closing Date in
proportion to the number of days in each such period.
· Tax
Audits.
· If
notice of any Legal Proceeding with respect to Taxes of the Company or any
of
the Subsidiaries (a “Tax Claim”) shall be received by
either party for which the other party may reasonably be expected to be liable
pursuant to Section 8.5(a), the notified party shall notify such other
party in writing of such Tax Claim; provided, however, that the
failure of the notified party to give the other party notice as provided herein
shall not relieve such failing party of its obligations under this Section
8.5 except to the extent that the other party is actually and materially
prejudiced thereby.
· Purchaser
shall have the right, at the expense of the Selling Stockholders to the extent
such Tax Claim is subject to indemnification by the Selling Stockholders
pursuant to Section 8.5(a) hereof, to represent the interests of the
Company and the Subsidiaries in any Tax Claim, provided that with respect
to a Tax Claim relating exclusively to taxable periods ending on or before
the
Closing Date, the Stockholder Representative shall represent the interests
of
the Company and shall not settle such claim without the consent of Purchaser,
which consent shall not be unreasonably withheld.
· Transfer
Taxes. Purchaser shall be liable for and shall pay (and shall
indemnify and hold harmless the Selling Stockholders against) all sales, use,
stamp, documentary, filing, recording, transfer or similar fees or taxes or
governmental charges as levied by any Governmental Body including any interest
and penalties) in connection with the transactions contemplated by this
Agreement.
· Disputes. Any
dispute as to any matter covered hereby shall be resolved by an independent
accounting firm mutually acceptable to the Stockholder Representative and the
Purchaser. The fees and expenses of such accounting firm shall be
borne equally by the Selling Stockholders, on the one hand, and the Purchaser
on
the other. If any dispute with respect to a Tax Return is not
resolved prior to the due date of such Tax Return, such Tax Return shall be
filed in the manner which the party responsible for preparing such Tax Return
deems correct.
· Time
Limits. Any claim for indemnity under this Section 8.5 may
be made at any time prior to ninety (90) days after the expiration of the
applicable Tax statute of limitations with respect to the relevant taxable
period (including all periods of extension, whether automatic or
permissive).
· Exclusivity. The
indemnification provided for in this Section 8.5 shall be the sole remedy
for any claim in respect of Taxes, including any claim arising out of or
relating to a breach of Section 4.10. In the event of a
conflict between the provisions of this Section 8.5, on the one hand, and
the provisions of Sections 8.1 through 8.4, on the other, the
provisions of this Section 8.5 shall control.
1.85 Indemnity
Escrow. On the Closing Date, Purchaser shall deposit with First
National Bank of Omaha (the “Escrow Agent”), as agent to
Purchaser and the Stockholder Representation (on behalf of the Selling
Stockholders), in immediately available funds, to the account designated by
the
Escrow Agent, and amount equal to $5,000,000.00 (the “Indemnity
Escrow Amount”), in accordance with the terms of this Agreement and
the Escrow Agreement, which will be executed at the Closing, by and among
Purchaser, the Stockholder Representative and the Escrow Agent (the
“Escrow Agreement”). Any payment the Selling
Stockholders are obligated to make to any Purchaser Indemnified Parties pursuant
to this Article VIII shall be paid first, to the extent there are
sufficient funds in the Indemnity Escrow Account, by release of funds to the
Purchaser Indemnified Parties from the Indemnity Escrow Account by the Escrow
Agent in accordance with the terms of the Escrow Agreement and shall accordingly
reduce the Indemnity Escrow Amount and, second, to the extent the Indemnity
Escrow Amount is insufficient (and such claims are not subject to the Cap
limitation under Section 8.4(c)) to pay any remaining sums due, then the
Selling Stockholders shall be required to pay all of such additional sums due
and owing to the applicable Purchaser Indemnified Party by wire transfer of
immediately available funds within five (5) Business Days after the date of
such
notice. On the first (1st) anniversary
of
the Closing Date, the Escrow Agent shall release the Indemnity Escrow Amount
(to
the extent not utilized to pay any Purchaser Indemnified Parties for any
indemnification claim) to the Stockholder Representative (for distribution
to
the Selling Stockholders in accordance with their respective pro rata
portion of the Purchase Price), except that the Escrow Agent shall retain an
amount (up to the total amount then held by the Escrow Agent) equal to the
amount of claims for indemnification under this Article VIII asserted
prior to such first (1st) anniversary
but
not yet resolved (“Unresolved Claims”). The
Indemnity Escrow Amount retained for Unresolved Claims shall be released by
the
Escrow Agent (to the extent not utilized to pay Purchaser Indemnified Parties
for any such claims resolved in favor thereof) upon their resolution in
accordance with this Article VIII and the terms of the Escrow
Agreement.
1.86 Treatment
of Indemnity Payments. The Selling Stockholders and the Purchaser
agree to treat any indemnity payment made pursuant to this Article VIII
as an adjustment to the Purchase Price for all purposes, including relating
to
income Taxes.
1.87 Exclusive
Remedy. Except for claims for intentional acts of fraud by any of
the Controlling Owner, the chief financial officer or chief operating officer
of
the Company, from and after the Closing, the sole and exclusive remedy available
to the parties hereto for claims arising out of the subject matter of this
Agreement shall be indemnification in accordance with this Article
VIII. Notwithstanding the foregoing, this Section 8.8
shall not (i) operate to interfere with or impede the operation under
Sections 2.7, 2.8, 9.3 or this Article VIII for the
resolution of certain disputes and payment of funds in respect thereof or (ii)
limit the rights of the parties to seek non-monetary equitable remedies
(including specific performance or injunctive relief).
TERMINATION
1.88 Termination
of Agreement. This Agreement may be terminated prior to the
Closing as follows:
· At
the election of the Stockholder Representative or Purchaser after October 1,
2007 (such date, as it may be extended under this Section 9.1(a), the
“Termination Date”), if the Closing shall not have
occurred by the close of business on such date, provided that the
terminating party is not in material default of any of its obligations
hereunder; and provided, further, that either Purchaser or the
Stockholder Representative shall have the option to extend, from time to time,
the Termination Date for additional periods of time not to exceed 60 days in
the
aggregate if all other conditions to the Closing are satisfied or capable of
then being satisfied and the sole reason that the Closing has not been
consummated is that the condition set forth in Section 7.1(f) has not
been satisfied due to the failure to obtain the necessary consents and approvals
under applicable Laws;
· by
mutual written consent of the Stockholder Representative and
Purchaser;
· by
the Stockholder Representative or Purchaser if there shall be in effect a final
nonappealable Order of a Governmental Body of competent jurisdiction
restraining, enjoining or otherwise prohibiting the consummation of the
transactions contemplated hereby; provided, however, that the
right to terminate this Agreement under this Section 9.1(c) shall not be
available to a party if such Order was primarily due to the failure of such
party to perform any of its obligations under this Agreement;
· by
Purchaser if any Selling Stockholder or the Company shall have breached or
failed to perform any of its representations, warranties, covenants or
agreements set forth in this Agreement, or if any representation or warranty
of
any Selling Stockholder or the Company shall have become untrue, in either
case
such that the conditions set forth in Sections 7.1(a) or
7.1(b) would not be satisfied and such breach is incapable of being
cured
or, if
· capable
of being cured, shall not have been cured within ten (10) days following receipt
by the Stockholder Representative of notice of such breach from the Purchaser;
or
· by
the Stockholder Representative if Purchaser shall have breached or failed to
perform any of its representations, warranties, covenants or agreements set
forth in this Agreement, or if any representation or warranty of Purchaser
shall
have become untrue, in either case such that the conditions set forth in
Sections 7.2(a) or 7.2(b) would not be satisfied and such breach
is incapable of being cured or, if capable of being cured, shall not have been
cured within ten (10) days following receipt by Purchaser of notice of such
breach from the Stockholder Representative.
1.89 Procedure
Upon Termination. In the event of termination and abandonment by
Purchaser or the Stockholder Representative, or both, pursuant to Section
9.1, written notice thereof shall forthwith be given to the other party or
parties, and this Agreement shall terminate, and the purchase of the Shares
hereunder shall be abandoned, without further action by Purchaser, the Company
or the Selling Stockholders; provided, however, that the
obligations of the parties under Section 6.9, Section 9.3 and
Article X shall remain in full force and effect.
1.90 Effect
of Termination. In the event that this Agreement is validly
terminated as provided herein, then each of the parties shall be relieved of
their duties and obligations arising under this Agreement after the date of
such
termination and such termination shall be without liability to Purchaser, any
Selling Stockholder or the Company; provided, however, that in the
event that this Agreement is terminated by the Stockholder Representative
pursuant to Section 9.1(e) (for any reason other than solely for to the
failure of the Closing to be consummated due to the failure to satisfy the
conditions set forth in Section 7.1(f) or Section 7.1(g) at such
time as the Stockholder Representative, the other Selling Stockholders and
the
Company are not in material default of any of their respective obligations
hereunder) or by Purchaser pursuant to Sections 9.1(d) (for any reason
other than solely for to the failure of the Closing to be consummated due to
the
failure to satisfy the conditions set forth in Section 7.1(f) or
Section 7.1(g) at such time as Purchaser is not in material default of
any of its obligations hereunder), then the Company, if the Stockholder
Representative is such terminating party, or Purchaser, if Purchaser is such
terminating party, shall pay to Purchaser (if the Stockholder Representative
is
such terminating party) or the Company (if Purchaser is such terminating party)
a termination fee equal to $2,500,000.00 (as liquidated damages for any such
termination. Any payment required by the immediately foregoing
sentence shall be made by the applicable party within five (5) Business Days
after such applicable termination. The obligations of the parties set
forth in this Section 9.3, Section 6.9 and Article X hereof
shall survive any such termination and shall be enforceable
hereunder.
MISCELLANEOUS
1.91 Expenses. Except
as otherwise provided in this Agreement, each of the Selling Stockholders and
Purchaser shall each bear its own expenses incurred in connection
with
1.92 the
negotiation and execution of this Agreement and each other agreement, document
and instrument contemplated by this Agreement and the consummation of the
transactions contemplated hereby. Unpaid Company Transaction Expenses
shall be accrued by the Company and its Subsidiaries and shall either be
incorporated into the adjustment as provided under Section 2.7 as
Included Current Liabilities for purposes of calculation of Closing Working
Capital or otherwise be an obligation of the Selling Stockholders as provided
under Section 8.2(a)(iv). Notwithstanding anything to the
contrary herein, Purchaser shall be responsible for and shall pay the fees
associated with filings required by the HSR Act.
1.93 Stockholder
Representative.
· Each
Selling Stockholder hereby irrevocably appoints Xxxxxx X. Xxxxx (the
“Stockholder Representative”) as such Selling
Stockholder’s representative, attorney-in-fact and agent, with full power of
substitution to act in the name, place and stead of such Selling Stockholder
with respect to the transfer of such Selling Stockholder’s Shares to Purchaser
in accordance with the terms and provisions of this Agreement and to act on
behalf of such Selling Stockholder in any amendment of or litigation or
arbitration involving this Agreement and to do or refrain from doing all such
further acts and things, and to execute all such documents, as such Stockholder
Representative shall deem necessary or appropriate in conjunction with any
of
the transactions contemplated by this Agreement, including the
power:
· to
take all action necessary or desirable in connection with the waiver of any
condition to the obligations of the Selling Stockholders to consummate the
transactions contemplated by this Agreement;
· to
negotiate, execute and deliver all ancillary agreements, statements,
certificates, statements, notices, approvals, extensions, waivers, undertakings,
amendments and other documents required or permitted to be given in connection
with the consummation of the transactions contemplated by this Agreement (it
being understood that such Selling Stockholder shall execute and deliver any
such documents which the Stockholder Representative agrees to
execute);
· to
terminate this Agreement if the Selling Stockholders are entitled to do
so;
· to
give and receive all notices and communications to be given or received under
this Agreement and to receive service of process in connection with the any
claims under this Agreement, including service of process in connection with
arbitration; and
· to
take all actions which under this Agreement may be taken by the Selling
Stockholders and to do or refrain from doing any further act or deed on behalf
of the Selling Stockholder which the Stockholder Representative deems necessary
or appropriate in his sole discretion relating to the subject matter of this
Agreement as fully and completely as such Selling Stockholder could do if
personally present.
· If
Xxxxxx X. Xxxxx becomes unable to serve as Stockholder
Representative, Xxxxxxxxxxx X. Xxxxx, or such other Person or Persons
as may be designated by a majority of the Selling Stockholders, shall succeed
as
the Stockholder Representative.
1.94 Specific
Performance. The Selling Stockholders acknowledge and agree that
a breach of this Agreement would cause irreparable damage to Purchaser and
that
Purchaser will not have an adequate remedy at law. Therefore, the
obligations of the Selling Stockholders under this Agreement to sell the Shares
to Purchaser, shall be enforceable by a decree of specific performance issued
by
any court of competent jurisdiction, and appropriate injunctive relief may
be
applied for and granted in connection therewith. Such remedy shall,
however, be cumulative and not exclusive and shall be in addition to any other
remedies which any party may have under this Agreement.
1.95 Submission
to Jurisdiction; Consent to Service of Process; Waiver of Jury
Trial.
· Except
as otherwise specifically provided under Sections 2.7(b), 2.8
(with respect to clauses (a)(iii) and (b)(iii) of Schedule 2.8) and
8.5(g), the parties hereto hereby irrevocably submit to the non-exclusive
jurisdiction of any federal or state court located within the State of Nebraska
over any dispute arising out of or relating to this Agreement or any of the
transactions contemplated hereby and each party hereby irrevocably agrees that
all claims in respect of such dispute or any suit, action proceeding related
thereto may be heard and determined in such courts. The parties
hereby irrevocably waive, to the fullest extent permitted by applicable law,
any
objection which they may now or hereafter have to the laying of venue of any
such dispute brought in such court or any defense of inconvenient forum for
the
maintenance of such dispute. Each of the parties hereto agrees that a
judgment in any such dispute may be enforced in other jurisdictions by suit
on
the judgment or in any other manner provided by law.
· Each
of the parties hereto hereby consents to process being served by any party
to
this Agreement in any suit, action or proceeding by delivery of a copy thereof
in accordance with the provisions of Section 10.7.
· THE
PARTIES TO THIS AGREEMENT EACH HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED
BY
LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION
(i) ARISING UNDER THIS AGREEMENT OR (ii) IN ANY WAY CONNECTED WITH OR RELATED
OR
INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS AGREEMENT
OR
ANY OF THE TRANSACTIONS RELATED HERETO, IN EACH CASE WHETHER NOW EXISTING OR
HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY, OR
OTHERWISE. THE PARTIES TO THIS AGREEMENT EACH HEREBY AGREES AND
CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION SHALL BE
DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES TO THIS AGREEMENT
MAY
FILE AN ORIGINAL COUNTERPART OF A COPY OF THIS AGREEMENT WITH ANY COURT AS
WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR
RIGHT TO TRIAL BY JURY.
· Entire
Agreement; Amendments and Waivers. This Agreement (including the
schedules and exhibits hereto), the Confidentiality Agreement, the Selling
Stockholder Documents and the Purchaser Documents represent the entire
understanding and agreement between the parties hereto with respect to the
subject matter hereof and can be amended, supplemented or changed, and any
provision hereof can be waived, only by written instrument making specific
reference to this Agreement signed by the party against whom enforcement of
any
such amendment, supplement, modification or waiver is sought. No
action taken pursuant to this Agreement shall be deemed to constitute a waiver
by the party taking such action of compliance with any representation, warranty,
covenant or agreement contained herein. The waiver by any party
hereto of a breach of any provision of this Agreement shall not operate or
be
construed as a further or continuing waiver of such breach or as a waiver of
any
other or subsequent breach. No failure on the part of any party to
exercise, and no delay in exercising, any right, power or remedy hereunder
shall
operate as a waiver thereof, nor shall any single or partial exercise of such
right, power or remedy by such party preclude any other or further exercise
thereof or the exercise of any other right, power or remedy.
1.96 Governing
Law. This Agreement shall be governed by and construed in
accordance with the laws of the State of Nebraska applicable to contracts made
and performed in such state.
1.97 Notices. All
notices and other communications under this Agreement shall be in writing and
shall be deemed given (i) when delivered personally by hand (with written
confirmation of receipt), (ii) when sent by facsimile (with written confirmation
of transmission) or (iii) one Business Day following the day sent by overnight
courier (with written confirmation of receipt), in each case at the following
addresses and facsimile numbers (or to such other address or facsimile number
as
a party may have specified by notice given to the other party pursuant to this
provision):
If
to the
Company (on or prior to the Closing Date) or any Selling Stockholder,
to:
c/o
Precision
Industries, Inc.
0000
X.
00xx
Xxxxxx
Xxxxx,
XX
00000
Facsimile: (000)
000-0000
Attention: Xxxxxx
X. Xxxxx, Chairman of the Board and Chief Executive Officer
With
a
copy to:
XxXxxxx
North
Xxxxxx & Xxxxx, PC LLO
First
National Tower, Suite 3700
0000
Xxxxx
Xxxxxx
Xxxxx,
XX
00000-0000
Facsimile: (000)
000-0000
Attention: Xxxxx
X. Xxxxxxxxxx
If
to
Purchaser, to:
DXP
Enterprises, Inc.
0000
Xxxxxxxx
Xxxxxxx,
XX
00000
Facsimile: (000)
000-0000
Attention: Xxxxx
X. Xxxxxx, Chief Executive Officer
With
a
copy to:
Xxxxxx
Xxxx
& McGraw, P.C.
0000
Xxxx Xxx
Xxxx., Xxxxx 0000
Xxxxxxx,
XX
00000
Facsimile: (000)
000-0000
Attention: Xxxxxxx
X. Xxxxxxx
1.98 Severability. If
any term or other provision of this Agreement is invalid, illegal, or incapable
of being enforced by any law or public policy, all other terms or provisions
of
this Agreement shall nevertheless remain in full force and effect so long as
the
economic or legal substance of the transactions contemplated hereby is not
affected in any manner materially adverse to any party. Upon such
determination that any term or other provision is invalid, illegal, or incapable
of being enforced, the parties hereto shall negotiate in good faith to modify
this Agreement so as to effect the original intent of the parties as closely
as
possible in an acceptable manner in order that the transactions contemplated
hereby are consummated as originally contemplated to the greatest extent
possible.
1.99 Binding
Effect; Assignment. This Agreement shall be binding upon and
inure to the benefit of the parties and their respective successors and
permitted assigns. Nothing in this Agreement shall create or be
deemed to create any third party beneficiary rights in any person or entity
not
a party to this Agreement except as provided below. No assignment of
this Agreement or of any rights or obligations hereunder may be made by either
the Selling Stockholders or Purchaser (by operation of law or otherwise) without
the prior written consent of the other parties hereto and any attempted
assignment without the required consents shall be void; provided,
however, that Purchaser may assign this Agreement and any or all rights
or obligations hereunder (including Purchaser’s rights to purchase the Shares
and Purchaser’s rights to seek indemnification hereunder) to any Affiliate of
Purchaser, any Person from which it has borrowed money or any Person to which
Purchaser or any of its Affiliates proposes to sell all or substantially all
of
the assets relating to the business, provided, Purchaser shall remain primarily
liable under this Agreement. Upon any such permitted assignment, the
references in this Agreement to Purchaser shall also apply to any such assignee
unless the context otherwise requires.
1.100 Non-Recourse. No
past, present or future director, officer, employee, incorporator, member,
partner, stockholder, Affiliate, agent, attorney or representative of Purchaser
shall have any liability for any obligations or liabilities of Purchaser under
this Agreement or for any claim based on, in respect of, or by reason of, the
transactions contemplated hereby.
1.101 Counterparts. This
Agreement may be executed in one or more counterparts (including by facsimile),
each of which will be deemed to be an original copy of this Agreement and all
of
which, when taken together, will be deemed to constitute one and the same
agreement, and shall become effective when one or more counterparts have been
signed by each of the parties and delivered to the other parties.
**
REMAINDER OF PAGE INTENTIONALLY LEFT BLANK**
IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly
executed as of the date first written above.
DXP
ENTERPRISES, INC.
By:
/s/Xxxxx X.
Xxxxxx
Xxxxx
X.
Xxxxxx, Chief Executive Officer
PRECISION
INDUSTRIES, INC.
By:
/s/Xxxxxx X.
Xxxxx
Xxxxxx
X.
Xxxxx, Chief Executive Officer
SELLING
STOCKHOLDERS:
XXXXXX
X.
XXXXX
/s/Xxxxxx
X.
Xxxxx
XXXXXXXXXXX
X. XXXXX
/s/Xxxxxxxxxxx
X.
Xxxxx
CIRCO
ENTERPRISES, LLC
By:
/s/Xxxxxx X.
Xxxxx
Name: Xxxxxx
X. Circots:
Its: Manager
CIRCO
HOLDINGS, LLC
By:
/s/Xxxxxx X.
Xxxxx
Name:
Xxxxxx X. Xxxxx
Its: Manager
XXXXXX
X.
XXXXX IRREVOCABLE TRUST NO. 4
By:
Security National Bank, Trustee
/s/Xxxxxxx
X.
Xxxxxxx
Name: Xxxxxxx
X. Xxxxxxx
Its: Senior
Vice President
Schedules
and exhibits omitted pursuant to Item 601(b)(3) of Regulation
S-K.